Unnamed: 0,title,date,stock,sentiment
448321.0,"Shares of several healthcare companies are trading higher on continued optimism amid the reopening of the economy, which would increase consumer spending and economic activity.",2020-06-08 11:41:00-04:00,EW,positive
448322.0,Edwards SAPIEN 3 Transcatheter Heart Valve Receives Approval In China,2020-06-08 10:39:00-04:00,EW,positive
448323.0,Stocks That Hit 52-Week Lows On Friday,2020-06-05 10:40:00-04:00,EW,negative
448324.0,"Cramer Gives His Opinion On Microsoft, Roku And More",2020-06-04 10:27:00-04:00,EW,neutral
448325.0,"Credit Suisse Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $88",2020-06-02 08:16:00-04:00,EW,positive
448326.0,Stocks That Hit 52-Week Lows On Monday,2020-06-01 10:43:00-04:00,EW,negative
448327.0,"Morgan Stanley Maintains Overweight on Edwards Lifesciences, Lowers Price Target to $83",2020-06-01 08:54:00-04:00,EW,negative
448328.0,Edwards Lifesciences Start Trading Post 3:1 Stock Split Today,2020-06-01 08:36:00-04:00,EW,neutral
448329.0,"Shares of several healthcare companies are trading higher amid market strength. Strength potentially related to coronavirus efforts including testing, vaccine development and treatment measures from several names in the sector.",2020-05-28 12:33:00-04:00,EW,positive
448330.0,Edwards Lifesciences shares are trading higher after the company's PASCAL transcatheter valve repair system received European approval for tricuspid repair.,2020-05-18 09:49:00-04:00,EW,positive
448331.0,Edwards Lifesciences PASCAL Transcatheter Valve Repair System Receives European Approval For Tricuspid Repair,2020-05-18 06:27:00-04:00,EW,positive
448332.0,Shares of several healthcare companies are trading higher amid positive investor sentiment as some US states begin to reopen their economies and as oil prices gain for the session.,2020-05-05 12:44:00-04:00,EW,positive
448333.0,Shares of several healthcare companies are trading lower as markets dip following recent strength. Markets have sold off as investors weigh recent earnings and amid concerns of renewed US-China trade frictions.,2020-05-01 12:35:00-04:00,EW,positive
448334.0,"Cramer Shares His Thoughts On Slack, Archer Daniels Midland And More",2020-04-28 09:17:00-04:00,EW,positive
448335.0,"Benzinga Pro's Top 4 Stocks To Watch For Tues., Apr. 28, 2020: BA, FFIV, EW, ATIF",2020-04-28 07:54:00-04:00,EW,positive
448336.0,"Wells Fargo Downgrades Edwards Lifesciences to Equal-Weight, Announces $230 Price Target",2020-04-28 05:16:00-04:00,EW,positive
448337.0,Edwards Lifesciences Reports Its HemoSphere Platform Receives Expanded Use Indication From Health Canada Related To Treatment for Coronavirus Patients,2020-04-27 16:34:00-04:00,EW,neutral
448338.0,"Raymond James Maintains Outperform on Edwards Lifesciences, Raises Price Target to $250",2020-04-24 11:58:00-04:00,EW,neutral
448339.0,"CFRA Maintains Buy on Edwards Lifesciences, Raises Price Target to $231",2020-04-24 11:37:00-04:00,EW,neutral
448340.0,"Stifel Maintains Buy on Edwards Lifesciences, Raises Price Target to $255",2020-04-24 11:18:00-04:00,EW,neutral
448341.0,"Citigroup Maintains Buy on Edwards Lifesciences, Raises Price Target to $255",2020-04-24 11:03:00-04:00,EW,neutral
448342.0,"Piper Sandler Maintains Overweight on Edwards Lifesciences, Lowers Price Target to $265",2020-04-24 10:20:00-04:00,EW,negative
448343.0,"Morgan Stanley Maintains Overweight on Edwards Lifesciences, Raises Price Target to $250",2020-04-24 08:51:00-04:00,EW,negative
448344.0,"The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO",2020-04-24 08:38:00-04:00,EW,positive
448345.0,"Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $250",2020-04-24 08:33:00-04:00,EW,negative
448346.0,"Credit Suisse Maintains Outperform on Edwards Lifesciences, Raises Price Target to $262",2020-04-24 08:32:00-04:00,EW,positive
448347.0,Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-04-24 08:22:00-04:00,EW,positive
448348.0,32 Stocks Moving in Friday's Pre-Market Session,2020-04-24 07:11:00-04:00,EW,neutral
448349.0,6 Stocks Moving In Thursday's After Hours Session,2020-04-23 17:11:00-04:00,EW,neutral
448350.0,Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-04-23 16:23:00-04:00,EW,positive
448351.0,"Edward's Lifesciences Cuts FY20 Adj. EPS Guidance From $6.15-$6.40 vs $4.75-$5.25 vs $5.10 Est., Cuts Sales Guidance From $4.6B-5.0B To $4B-$4.5B vs $4.37B Est.",2020-04-23 16:18:00-04:00,EW,negative
448352.0,"Edwards Lifesciences Q1 Adj. EPS $1.510 Beats $1.330 Estimate, Sales $1.100B Beat $1.080B Estimate",2020-04-23 16:15:00-04:00,EW,neutral
448353.0,"The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt",2020-04-23 07:53:00-04:00,EW,negative
448354.0,"Earnings Scheduled For April 23, 2020",2020-04-23 04:23:00-04:00,EW,neutral
448355.0,"The Week Ahead In Biotech (April 19-25): Eli Lilly, Biogen Earnings On Tap, Sanofi Awaits FDA Decision",2020-04-19 17:22:00-04:00,EW,positive
448356.0,"Benzinga's Top Upgrades, Downgrades For April 17, 2020",2020-04-17 09:31:00-04:00,EW,positive
448357.0,Edwards Lifesciences shares are trading higher after SVB Leerink upgraded the stock from Market Perform to Outperform.,2020-04-17 08:45:00-04:00,EW,positive
448358.0,SVB Leerink Upgrades Edwards Lifesciences to Outperform,2020-04-17 06:24:00-04:00,EW,neutral
448359.0,Shares of several healthcare companies are trading higher as markets gain on positive coronavirus outlook. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-14 10:59:00-04:00,EW,positive
448360.0,"Shares of several healthcare companies are trading lower amid overall market weakness. Stocks are lower, selling off from last week's gains amid uncertainty surrounding coronavirus outlook and the reopening of the economy.",2020-04-13 12:23:00-04:00,EW,negative
448361.0,Shares of several healthcare companies are trading higher amid overall market strength after the US Federal Reserve announced a further $2.3 trillion in financing programs to support the economy. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic and US Senator Sanders exiting the Presidential race.,2020-04-09 09:58:00-04:00,EW,positive
448362.0,Shares of several healthcare companies are trading higher amid optimism that coronavirus cases in Asia are potentially easing. Global slowing cases could raise hopes of a sooner return to spending and economic activity. Several companies in the sector may also be benefiting from increased demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-07 07:48:00-04:00,EW,positive
448363.0,Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. A sooner peak could mean a sooner return to economic activity.,2020-04-06 09:42:00-04:00,EW,positive
448364.0,"Wells Fargo Maintains Overweight on Edwards Lifesciences, Lowers Price Target to $215",2020-04-06 09:25:00-04:00,EW,negative
448365.0,Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.,2020-04-01 09:20:00-04:00,EW,negative
448366.0,"Morgan Stanley Maintains Overweight on Edwards Lifesciences, Lowers Price Target to $241",2020-03-27 09:29:00-04:00,EW,negative
448367.0,"Citigroup Maintains Buy on Edwards Lifesciences, Lowers Price Target to $240",2020-03-27 08:37:00-04:00,EW,negative
448368.0,"Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.",2020-03-26 11:49:00-04:00,EW,positive
448369.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,EW,negative
448370.0,Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,2020-03-23 11:31:00-04:00,EW,negative
448371.0,Stocks That Hit 52-Week Lows On Monday,2020-03-23 10:34:00-04:00,EW,negative
448372.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,EW,positive
448373.0,"Shares of several healthcare companies are trading lower as the coronavirus outbreak continues to cause economic disruption around the globe, leading to a steep selloff in equities across sectors.",2020-03-16 10:50:00-04:00,EW,negative
448374.0,"CORRECTION: CFRA Upgrades Edwards Lifesciences From Sell To Hold, Lowers Price Target To $201; Initial Headline Suggested Firm Maintained Sell, This Was Incorrect",2020-03-13 11:54:00-04:00,EW,negative
448375.0,"CFRA Upgrades Edwards Lifesciences From Sell To Hold, Lowers Price Target To $201",2020-03-13 11:47:00-04:00,EW,negative
448376.0,Shares of several healthcare companies are trading higher as markets rebound following Monday's selloff. US President Trump on Monday indicated the US may implement payroll tax cuts and other measures to support the economy amid the coronavirus outbreak.,2020-03-10 07:54:00-04:00,EW,positive
448377.0,"Credit Suisse Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $267",2020-03-06 10:31:00-05:00,EW,positive
448378.0,"Benzinga's Top Upgrades, Downgrades For March 5, 2020",2020-03-05 10:05:00-05:00,EW,positive
448379.0,"Citigroup Initiates Coverage On Edwards Lifesciences with Buy Rating, Announces $252 Price Target",2020-03-05 04:57:00-05:00,EW,neutral
448380.0,"Benzinga's Top Upgrades, Downgrades For February 13, 2020",2020-02-13 09:56:00-05:00,EW,positive
448381.0,"Goldman Sachs Initiates Coverage On Edwards Lifesciences with Neutral Rating, Announces $253 Price Target",2020-02-13 07:38:00-05:00,EW,neutral
448382.0,"CFRA Maintains Sell on Edwards Lifesciences, Raises Price Target to $207",2020-01-31 12:09:00-05:00,EW,neutral
448383.0,﻿Shares of several healthcare companies are trading lower as fears of the coronavirus' potential impact on the global economy intensifies. The death toll continues to rise and the U.K. and Russia confirmed their first cases.,2020-01-31 11:41:00-05:00,EW,negative
448384.0,"Stifel Nicolaus Maintains Buy on Edwards Lifesciences, Raises Price Target to $280",2020-01-31 10:14:00-05:00,EW,neutral
448385.0,"The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO",2020-01-31 09:09:00-05:00,EW,negative
448386.0,"Credit Suisse Maintains Outperform on Edwards Lifesciences, Raises Price Target to $278",2020-01-31 08:59:00-05:00,EW,positive
448387.0,"Deutsche Bank Maintains Hold on Edwards Lifesciences, Raises Price Target to $245",2020-01-31 08:57:00-05:00,EW,neutral
448388.0,"Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $272",2020-01-31 08:29:00-05:00,EW,negative
448389.0,"UBS Maintains Neutral on Edwards Lifesciences, Raises Price Target to $260",2020-01-31 08:18:00-05:00,EW,neutral
448390.0,"Piper Sandler Maintains Overweight on Edwards Lifesciences, Raises Price Target to $270",2020-01-31 08:15:00-05:00,EW,negative
448391.0,12 Stocks Moving In Thursday's After Hours,2020-01-30 17:23:00-05:00,EW,neutral
448392.0,Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q4 sales results. The company also issued Q1 sales guidance above analyst estimates and raised FY20 EPS guidance.,2020-01-30 16:24:00-05:00,EW,positive
448393.0,"Edwards Raises FY20 Guidance: Adj. EPS From $6.05-$6.30 To $6.15-$6.40 vs $6.16 Estimate, Narrows Sales From $4.5B-$5B To $4.6B-$5B vs $4.79B Est.",2020-01-30 16:18:00-05:00,EW,neutral
448394.0,"Edwards Lifesciences Sees Q1 Adj. EPS $1.49-$1.59 vs $1.50 Estimate, Sales $1.15B-$1.2B vs $1.14B Est.",2020-01-30 16:18:00-05:00,EW,neutral
448395.0,"Edwards Lifesciences Q4 EPS $1.46 Misses $1.48 Estimate, Sales $1.174B Beat $1.14B Estimate",2020-01-30 16:17:00-05:00,EW,negative
448396.0,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance",2020-01-30 09:26:00-05:00,EW,positive
448397.0,"Earnings Scheduled For January 30, 2020",2020-01-30 04:59:00-05:00,EW,neutral
448398.0,"The Week Ahead In Biotech: Amgen, Eli Lilly, Pfizer In Earnings Mix, IPO Flow Resumes",2020-01-26 10:23:00-05:00,EW,neutral
448399.0,23 Medical Devices Stocks Moving In Thursday's Session,2020-01-23 12:58:00-05:00,EW,neutral
448400.0,Edwards Lifesciences shares are trading lower. Not currently seeing any company-specific news.,2020-01-23 10:06:00-05:00,EW,neutral
448401.0,"Benzinga's Top Upgrades, Downgrades For January 3, 2020",2020-01-03 11:33:00-05:00,EW,positive
448402.0,"Evercore ISI Group Downgrades Edwards Lifesciences to In-Line, Announces $324 Price Target",2020-01-02 07:20:00-05:00,EW,neutral
448403.0,10 Biggest Price Target Changes For Monday,2019-12-09 08:53:00-05:00,EW,neutral
448404.0,"PiperJaffray Maintains Overweight on Edwards Lifesciences, Raises Price Target to $262",2019-12-09 07:28:00-05:00,EW,negative
448405.0,"UBS Maintains Neutral on Edwards Lifesciences, Raises Price Target to $255",2019-12-06 10:33:00-05:00,EW,neutral
448406.0,"Wells Fargo Maintains Outperform on Edwards Lifesciences, Raises Price Target to $270",2019-12-06 10:01:00-05:00,EW,positive
448407.0,"Credit Suisse Maintains Outperform on Edwards Lifesciences, Raises Price Target to $275",2019-12-06 08:44:00-05:00,EW,positive
448408.0,"Morgan Stanley Maintains Overweight on Edwards Lifesciences, Raises Price Target to $270",2019-12-06 08:21:00-05:00,EW,negative
448409.0,Edwards Lifesciences shares are trading lower. Not seeing any news to justify the price action. NOTE: The company outlined growth strategy during its annual investor conference today.,2019-12-05 10:15:00-05:00,EW,positive
448410.0,Shares of several healthcare stocks are trading lower as US equities dip following escalating US-China tensions over Hong Kong. US Stocks further fell on worse-than-expected manufacturing data.,2019-12-02 11:31:00-05:00,EW,negative
448411.0,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data",2019-11-20 07:25:00-05:00,EW,positive
448412.0,Stocks That Hit 52-Week Highs On Monday,2019-11-18 11:01:00-05:00,EW,neutral
448413.0,"UPDATE: Wells Fargo Said Talked To 2 Physicians About Edwards Recall, Physicians See Recall As Minor Issue",2019-11-15 13:39:00-05:00,EW,positive
448414.0,Hearing Wells Fargo Commented On Word Of Edwards Lifesciences Voluntarily Recall For PASCAL; Highlights Confirmation From Co. Issue Came To Light During Inspection Process,2019-11-15 13:37:00-05:00,EW,positive
448415.0,Edward Lifesciences Shares Down 0.4% Over Last Few Mins. As Traders Circulate Doc From Co. Intended For Physicians Alerting To Voluntarily Product Recall On Guide Sheath Used In Conjunction With Co.'s PASCAL Transcatheter Valve Repair System,2019-11-15 13:36:00-05:00,EW,positive
448416.0,Stocks That Hit 52-Week Highs On Friday,2019-11-15 10:14:00-05:00,EW,neutral
448417.0,"The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing",2019-11-14 08:07:00-05:00,EW,positive
448418.0,Edwards Lifesciences Says SAPIEN 3 TAVI Receives Expanded Approval In Europe,2019-11-06 03:54:00-05:00,EW,positive
448419.0,Stocks That Hit 52-Week Highs On Friday,2019-11-01 10:31:00-04:00,EW,neutral
448420.0,"The Daily Biotech Pulse: Novartis Program Placed On Partial Clinical Hold, Adcom Snub For Amag, Amgen Earnings",2019-10-30 07:01:00-04:00,EW,negative
448421.0,Stocks That Hit 52-Week Highs On Tuesday,2019-10-29 10:52:00-04:00,EW,neutral
448422.0,Edwards Lifesciences shares are trading higher on continued strength following last week's earnings report and guidance.,2019-10-28 13:19:00-04:00,EW,positive
448423.0,"The Daily Biotech Pulse: Melinta Crosses FDA Hurdle But Sees Liquidity Pushback, Positive Readout For Aclaris Wart Drug",2019-10-25 07:12:00-04:00,EW,positive
448424.0,Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also raised FY19 EPS guidance above analyst estimates.,2019-10-24 10:22:00-04:00,EW,positive
448425.0,Stocks That Hit 52-Week Highs On Thursday,2019-10-24 10:13:00-04:00,EW,neutral
448426.0,"Deutsche Bank Maintains Hold on Edwards Lifesciences, Raises Price Target to $236",2019-10-24 10:03:00-04:00,EW,neutral
448427.0,"Stifel Nicolaus Maintains Buy on Edwards Lifesciences, Raises Price Target to $250",2019-10-24 09:37:00-04:00,EW,neutral
448428.0,"Morgan Stanley Maintains Overweight on Edwards Lifesciences, Raises Price Target to $248",2019-10-24 09:25:00-04:00,EW,negative
448429.0,"Bank of America Reiterates Buy on Edwards Lifesciences, Raises Price Target to $250",2019-10-24 08:09:00-04:00,EW,neutral
448430.0,"Wells Fargo Maintains Outperform on Edwards Lifesciences, Raises Price Target to $262",2019-10-24 07:49:00-04:00,EW,positive
448431.0,"Raymond James Maintains Outperform on Edwards Lifesciences, Raises Price Target to $255",2019-10-24 07:49:00-04:00,EW,neutral
448432.0,"The Daily Biotech Pulse: Acorda To Trim Jobs, GlaxoSmithKline Gets FDA Nod, Edward Lifesciences Posts Q3 Beat-And-Raise",2019-10-24 07:36:00-04:00,EW,neutral
448433.0,Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q3 EPS and sales results. The company also raised FY19 EPS guidance above analyst estimates.,2019-10-23 16:24:00-04:00,EW,positive
448434.0,Edwards Life Science Raised Its FY19 EPS Guidance From $5.20 - $5.40 to $5.50 - $5.65 vs $5.34 Estimate,2019-10-23 16:20:00-04:00,EW,neutral
448435.0,Edwards Lifesciences Q3 Adj. EPS $1.41 vs $1.22 Estimate,2019-10-23 16:20:00-04:00,EW,neutral
448436.0,"Edwards Lifesciences Q3 EPS $1.3 Beats $1.22 Estimate, Sales $1.1B Beat $1.04B Estimate",2019-10-23 16:18:00-04:00,EW,neutral
448437.0,"The Daily Biotech Pulse: Eli Lily Revenues Trail Estimates, Moderna Gets Fast Track Designation, MacroGenics' Lukewarm Breast Cancer Data",2019-10-23 07:54:00-04:00,EW,negative
448438.0,"Earnings Scheduled For October 23, 2019",2019-10-23 04:15:00-04:00,EW,neutral
448439.0,"The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict",2019-10-20 08:08:00-04:00,EW,positive
448440.0,"UBS Maintains Neutral on Edwards Lifesciences, Raises Price Target to $230",2019-10-16 09:23:00-04:00,EW,neutral
448441.0,"Credit Suisse Maintains Outperform on Edwards Lifesciences, Raises Price Target to $261",2019-10-14 09:04:00-04:00,EW,positive
448442.0,"Raymond James Maintains Outperform on Edwards Lifesciences, Raises Price Target to $250",2019-10-14 08:33:00-04:00,EW,neutral
448443.0,Shares of several healthcare companies are trading higher after multiple reports suggesting China is open to a partial trade deal surfaced. The reports renewed optimism in the upcoming U.S.-China trade talks.,2019-10-09 11:10:00-04:00,EW,positive
448444.0,Stocks That Hit 52-Week Highs On Friday,2019-10-04 12:45:00-04:00,EW,neutral
448445.0,"Benzinga's Top Upgrades, Downgrades For September 23, 2019",2019-09-23 12:47:00-04:00,EW,positive
448446.0,"Piper Jaffray Initiates Coverage On Edwards Lifesciences with Overweight Rating, Announces $240 Price Target",2019-09-23 06:44:00-04:00,EW,negative
448447.0,Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival.,2019-09-20 13:00:00-04:00,EW,negative
448448.0,Shares of several diagnostics/medical device companies trading lower with broader market. DexCom shares leading the group lower following comments from Morgan Stanley about pressure on the company's Q3 comps.,2019-09-09 12:48:00-04:00,EW,negative
448449.0,Stocks That Hit 52-Week Highs On Friday,2019-09-06 12:23:00-04:00,EW,neutral
448450.0,"Wells Fargo Maintains Outperform on Edwards Lifesciences, Raises Price Target to $250",2019-09-06 09:51:00-04:00,EW,positive
448451.0,Edwards Lifesciences Shares Fall As FDA Reports Recall Of Sapien 3 Ultra,2019-08-22 11:29:00-04:00,EW,positive
448452.0,Hearing Edwards Lifesciences's SAPIEN Represents 60% Of Their Sales,2019-08-22 11:26:00-04:00,EW,neutral
448453.0,FDA Reports Edwards Lifesciences Recalls SAPIEN 3 Ultra Delivery System,2019-08-22 11:04:00-04:00,EW,neutral
448454.0,Stocks That Hit 52-Week Highs On Tuesday,2019-08-20 10:27:00-04:00,EW,neutral
448455.0,Shares of several healthcare companies are trading higher as optimism increased for a resolution to the US-China trade war.,2019-08-19 12:31:00-04:00,EW,positive
448456.0,Stocks That Hit 52-Week Highs On Monday,2019-08-19 10:53:00-04:00,EW,neutral
448457.0,"Shares of healthcare companies are trading higher as US markets rebound from recent weakness following a yield curve inversion, which caused recession fears. Trump also recently announced the US would delay China tariffs, renewing hopes of a trade deal.",2019-08-16 13:27:00-04:00,EW,negative
448458.0,Edwards Sapien 3 TAVR Receives FDA Approval For Low-Risk Patients; Sapien 3 TAVR's Low-Risk Approval Was Based On Data From Landmark Partner 3 Trial,2019-08-16 11:58:00-04:00,EW,positive
448459.0,"The Daily Biotech Pulse: Setback For Bristol-Myers Squibb, Gemphire Explodes, Lilly's Nasal Low Blood Sugar Drug",2019-07-25 07:21:00-04:00,EW,negative
448460.0,50 Biggest Movers From Yesterday,2019-07-25 05:50:00-04:00,EW,neutral
448461.0,38 Stocks Moving In Wednesday's Mid-Day Session,2019-07-24 13:57:00-04:00,EW,neutral
448462.0,10 Biggest Price Target Changes For Wednesday,2019-07-24 12:02:00-04:00,EW,neutral
448463.0,"BMO Capital Reiterates Outperform on Edwards Lifesciences, Raises Price Target to $224",2019-07-24 09:09:00-04:00,EW,neutral
448464.0,"JP Morgan Maintains Neutral on Edwards Lifesciences, Raises Price Target to $225",2019-07-24 08:51:00-04:00,EW,positive
448465.0,"Canaccord Genuity Maintains Buy on Edwards Lifesciences, Raises Price Target to $250",2019-07-24 08:14:00-04:00,EW,neutral
448466.0,"Morgan Stanley Maintains Overweight on Edwards Lifesciences, Raises Price Target to $228",2019-07-24 08:09:00-04:00,EW,negative
448467.0,"Credit Suisse Maintains Outperform on Edwards Lifesciences, Raises Price Target to $226",2019-07-24 08:01:00-04:00,EW,positive
448468.0,Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q2 EPS and sales guidance. The company also raised FY19 EPS and sales guidance.,2019-07-24 07:59:00-04:00,EW,positive
448469.0,24 Stocks Moving In Wednesday's Pre-Market Session,2019-07-24 07:58:00-04:00,EW,neutral
448470.0,"Raymond James Maintains Outperform on Edwards Lifesciences, Raises Price Target to $232",2019-07-24 07:43:00-04:00,EW,neutral
448471.0,"Barclays Maintains Underweight on Edwards Lifesciences, Raises Price Target to $175",2019-07-24 07:32:00-04:00,EW,neutral
448472.0,"The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index",2019-07-24 07:08:00-04:00,EW,neutral
448473.0,"14 Stocks To Watch For July 24, 2019",2019-07-24 04:53:00-04:00,EW,neutral
448474.0,Edwards Lifesciences shares are trading higher after the company reported better-than-expected Q2 EPS and sales guidance. The company also raised FY19 EPS and sales guidance.,2019-07-23 16:22:00-04:00,EW,positive
448475.0,"UPDATE: Edwards Lifesciences Raises FY19 Guidance: Sales $4B-$4.3B vs $4.16B Estimate, Adj. EPS From $5.10-$5.35 To $5.20-$5.40 vs $5.29 Est.",2019-07-23 16:16:00-04:00,EW,neutral
448476.0,Edwards Raises FY19 Guidance,2019-07-23 16:15:00-04:00,EW,neutral
448477.0,"Edwards Lifesciences Q2 Adj. EPS $1.38 Beats $1.33 Estimate, Sales $1.087B Beat $1.04B Estimate",2019-07-23 16:15:00-04:00,EW,neutral
448478.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,EW,negative
448479.0,"Earnings Scheduled For July 23, 2019",2019-07-23 04:51:00-04:00,EW,neutral
448480.0,The Week Ahead In Biotech: Pharma Earnings Pick Up Pace,2019-07-20 09:53:00-04:00,EW,neutral
448481.0,"Morgan Stanley Maintains Overweight on Edwards Lifesciences, Raises Price Target to $210",2019-07-16 08:43:00-04:00,EW,negative
448482.0,UK Ambassador To US Quits,2019-07-10 07:05:00-04:00,EW,neutral
448483.0,"FDA Says Edwards Lifesciences Has Recalled Intraclude Intra-Aortic Occlusion Device, Cites Risk Of Balloon Rupture",2019-07-01 15:47:00-04:00,EW,negative
448484.0,Mexican President Lopez Obrador Says Will Ask To Meet US President Trump In September,2019-06-21 10:14:00-04:00,EW,neutral
448485.0,Foreign Minister Ebrard Says Mexico On Thursday Will Launch Job Opportunities Plan For Salvadorans,2019-06-19 10:36:00-04:00,EW,positive
448486.0,Kudlow Says Passing US-Mexico-Canada Trade Deal More Important In Short Term Than China Trade Deal,2019-06-18 11:21:00-04:00,EW,positive
448487.0,"The Daily Biotech Pulse: ASCO Presentations From Roche, Celgene & More, Edwards Recommends Rejection Of Mini-Tender Offer",2019-06-04 07:45:00-04:00,EW,negative
448488.0,UPDATE: Edwards Says TRC Cap Made Offer To Buy 1M Shares At $162.38/Share,2019-06-03 16:19:00-04:00,EW,positive
448489.0,Edwards Lifesciences Recommends Shareholders Reject Offer By TRC Cap,2019-06-03 16:17:00-04:00,EW,negative
448490.0,"Fitch Ratings Says US Tariffs On Mexico May Threaten USMCA, Corporate Cash Flow",2019-06-03 12:36:00-04:00,EW,negative
448491.0,'Edwards Lifesciences LLC Recalls EV1000 Clinical Platforms Due to Electrical Short Circuit Which May Cause the Device to Stop Working or Catch Fire' -FDA,2019-05-24 09:51:00-04:00,EW,negative
448492.0,Analysts Shrug Off Softness In Edwards Lifesciences' Heart Value Replacement System,2019-04-24 11:22:00-04:00,EW,positive
448493.0,"Stifel Nicolaus Maintains Buy on Edwards Lifesciences Corporation Common Stock, Raises Price Target to $200",2019-04-24 10:32:00-04:00,EW,neutral
448494.0,"Deutsche Bank Maintains Hold on Edwards Lifesciences Corporation Common Stock, Raises Price Target to $184",2019-04-24 09:54:00-04:00,EW,neutral
448495.0,"Raymond James Maintains Outperform on Edwards Lifesciences Corporation Common Stock, Lowers Price Target to $200",2019-04-24 07:40:00-04:00,EW,negative
448496.0,Edwards Lifesciences Raises FY19 Adj. EPS Guidance From $5.05-$5.30 To $5.10-$5.35 vs $5.21 Est.,2019-04-23 16:27:00-04:00,EW,neutral
448497.0,"Edwards Lifesciences Sees Q2 Adj. EPS $1.27-$1.37 vs $1.33 Est., Sales $1.02B-$1.08B vs $1.04B Est.",2019-04-23 16:26:00-04:00,EW,neutral
448498.0,"Edwards Lifesciences Q1 Adj. EPS $1.32 Beats $1.23 Estimate, Sales $993M Beat $990.07M Estimate",2019-04-23 16:25:00-04:00,EW,neutral
448499.0,"Shares of several healthcare stocks are trading higher in a potential rebound from last week's selloff. In an upgrade of HCA Healthcare, Raymond James analysts noted the selloff was 'based on legislation that has almost no chance of passing'",2019-04-23 11:52:00-04:00,EW,positive
448500.0,"The Daily Biotech Pulse: FDA Accepts Alder's Migraine Drug Application, Gritstone Offering, Lilly's Chinese Sale",2019-04-23 08:08:00-04:00,EW,positive
448501.0,"Earnings Scheduled For April 23, 2019",2019-04-23 04:00:00-04:00,EW,neutral
448502.0,"The Week Ahead In Biotech: Conferences, Clinical Trial Readouts, Earnings And IPOs",2019-04-21 14:06:00-04:00,EW,neutral
448503.0,Shares of several healthcare companies are trading lower on continued weakness over concerns of 'Medicare for all' support within 2020 presidential candidates and the uncertainty over healthcare policy going into the election.,2019-04-18 10:42:00-04:00,EW,negative
448504.0,Shares of several healthcare companies are trading lower after Trump renewed his efforts to repeal and replace the Affordable Care Act; the Department of Justice moved to accelerate the appeal process in hopes to invalidate the ACA as unconstitutional.,2019-04-17 10:38:00-04:00,EW,positive
448505.0,"Credit Suisse Maintains Outperform on Edwards Lifesciences, Raises Price Target to $221",2019-04-15 11:14:00-04:00,EW,positive
448506.0,"The Daily Biotech Pulse: FDA Nod For Roche And Amphastar, Milestone Payment Kicks In For Affimed",2019-03-19 07:40:00-04:00,EW,neutral
448507.0,10 Biggest Price Target Changes For Monday,2019-03-18 10:16:00-04:00,EW,neutral
448508.0,"Morgan Stanley Maintains Overweight on Edwards Lifesciences, Raises Price Target to $197",2019-03-18 09:30:00-04:00,EW,negative
448509.0,Edwards Lifesciences shares are trading higher after Bank of America reiterated a Buy on the stock and raised the price target from $190 to $215.,2019-03-18 09:21:00-04:00,EW,positive
448510.0,"Bank of America Reiterates Buy on Edwards Lifesciences, Raises Price Target to $215",2019-03-18 08:30:00-04:00,EW,neutral
448511.0,"The Daily Biotech Pulse: Arsanis Completes X4 Merger, EC Nod For Roche, Axovant Offering",2019-03-14 07:47:00-04:00,EW,neutral
448512.0,"UBS Maintains Neutral on Edwards Lifesciences, Raises Price Target to $180",2019-03-12 09:44:00-04:00,EW,neutral
448513.0,"Edwards Lifesciences Acquires Corvia Medical for $35M, Edwards Also Acquires Certain Assets from Mitralign, Terms Not Disclosed",2019-03-11 08:35:00-04:00,EW,positive
448514.0,"Citigroup Maintains Sell on Edwards Lifesciences, Raises Price Target to $130",2019-02-25 10:29:00-05:00,EW,neutral
448515.0,Edwards Lifesciences Reports PASCAL Transcatheter System Received CE Mark,2019-02-19 16:18:00-05:00,EW,neutral
448516.0,"The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J's Depression Drug, MacroGenics Prices Offering",2019-02-13 07:49:00-05:00,EW,negative
448517.0,58 Biggest Movers From Yesterday,2019-02-13 04:43:00-05:00,EW,neutral
448518.0,Mid-Afternoon Market Update: Crude Oil Up Over 2%; Ellie Mae Shares Jump On Acquisition News,2019-02-12 14:30:00-05:00,EW,negative
448519.0,44 Stocks Moving In Tuesday's Mid-Day Session,2019-02-12 12:18:00-05:00,EW,neutral
448520.0,Mid-Day Market Update: Dow Rises Over 300 Points; Bristow Group Shares Plummet,2019-02-12 12:08:00-05:00,EW,positive
448521.0,CAS Medical Surges As Edwards Lifesciences Agrees To Buy Medtech Company In $100M Deal,2019-02-12 10:50:00-05:00,EW,positive
448522.0,CASMED Shares To Resume Trade At 9 a.m. EST,2019-02-12 08:58:00-05:00,EW,positive
448523.0,Edwards Lifesciences To Acquire CASMED For $2.45/Share In Cash,2019-02-12 08:32:00-05:00,EW,neutral
448524.0,Hearing FDA Recalls Swan-Ganz Thermodilution Catheter Due To Incorrect Assembly Causing Reversal Of Lumens,2019-02-05 14:59:00-05:00,EW,neutral
448525.0,"The Daily Biotech Pulse: Merck Earnings, Positive Relaunch Of  Titan's Opioid Disorder Treatment Implant",2019-02-01 09:10:00-05:00,EW,positive
448526.0,"Edwards Lifesciences Sees Q1 Adj. EPS $1.15-$1.25 vs $1.30 Est., Sales $950M-$1.01B vs $997.57M Est.",2019-01-31 16:19:00-05:00,EW,neutral
448527.0,"Edwards Lifesciences Q4 Adj.  EPS $1.17, Inline, Adj. Sales $983M Beat $975.92M Estimate",2019-01-31 16:18:00-05:00,EW,neutral
448528.0,"Earnings Scheduled For January 31, 2019",2019-01-31 04:01:00-05:00,EW,neutral
448529.0,"Bank of America Upgrades Edwards Lifesciences to Buy, Raises Price Target to $190",2019-01-18 07:39:00-05:00,EW,neutral
448530.0,55 Biggest Movers From Yesterday,2019-01-16 05:12:00-05:00,EW,neutral
448531.0,40 Stocks Moving In Tuesday's Mid-Day Session,2019-01-15 12:36:00-05:00,EW,neutral
448532.0,Edwards Lifesciences shares are trading higher after the company reached a settlement with Boston Scientific on all outstanding patent disputes.,2019-01-15 10:24:00-05:00,EW,positive
448533.0,UPDATE: Edwards Has Made 1-Time Payment Of $180M To Boston Scientific,2019-01-15 06:56:00-05:00,EW,neutral
448534.0,"Boston Scientific, Edwards Lifesciences Report Global Litigation Settlement",2019-01-15 06:55:00-05:00,EW,negative
448535.0,Edwards Lifesciences shares are trading lower after Deutsche Bank initiated coverage on the stock with a Hold rating and price target of $164.,2019-01-03 10:26:00-05:00,EW,neutral
448536.0,"Benzinga's Top Upgrades, Downgrades For January 3, 2019",2019-01-03 09:09:00-05:00,EW,positive
448537.0,"Deutsche Bank Initiates Coverage On Edwards Lifesciences with Hold Rating, Announces $164 Price Target",2019-01-03 07:54:00-05:00,EW,neutral
448538.0,Edwards' SAPIEN 3 Ultra Transcatheter Heart Valve Receives FDA Approval,2018-12-28 08:30:00-05:00,EW,positive
448539.0,"Credit Suisse Initiates Coverage On Edwards Lifesciences with Outperform Rating, Announces $188 Price Target",2018-12-18 07:23:00-05:00,EW,positive
448540.0,"Jim Cramer Gives His Opinion On Walmart, IBM And More",2018-12-14 07:35:00-05:00,EW,neutral
448541.0,"The Daily Biotech Pulse: Legal Victory For Boston Scientific, Alder Gets New CFO, FDA Go-Ahead For BioXcel",2018-12-12 08:07:00-05:00,EW,positive
448542.0,Edwards Comments On U.S. Court Decision,2018-12-12 04:24:00-05:00,EW,neutral
448543.0,"Morgan Stanley Maintains Overweight on Edwards Lifesciences, Raises Price Target to $180",2018-12-07 07:56:00-05:00,EW,negative
448544.0,"Raymond James Maintains Outperform on Edwards Lifesciences, Raises Price Target to $175",2018-12-06 08:33:00-05:00,EW,neutral
448545.0,"Jefferies Maintains Buy on Edwards Lifesciences, Raises Price Target to $180",2018-12-06 08:25:00-05:00,EW,neutral
448546.0,From Annual Investor Conference: Edwards Lifesciences Sees 2019 Underlying Sales Growth of 9%-12%,2018-12-05 09:35:00-05:00,EW,positive
448547.0,From Annual Investor Conference: Edwards Lifesciences Reaffirms Estimated 2019 Adjusted EPS $5.05-5.30 vs $5.21 Analyst Est,2018-12-05 09:33:00-05:00,EW,neutral
448548.0,Edwards Lifesciences Reports Received FDA Clearance For HemoSphere Platform,2018-12-03 08:34:00-05:00,EW,neutral
448549.0,"Benzinga's Top Upgrades, Downgrades For November 28, 2018",2018-11-28 08:59:00-05:00,EW,positive
448550.0,"UBS Initiates Coverage On Edwards Lifesciences with Neutral Rating, Announces $165 Price Target",2018-11-28 08:00:00-05:00,EW,neutral
448551.0,9 Policy Catalysts For Health Care Investors To Watch Before Year's End,2018-11-25 09:35:00-05:00,EW,positive
448552.0,"Citigroup Maintains Sell on Edwards Lifesciences, Lowers Price Target to $118",2018-10-29 09:49:00-04:00,EW,negative
448553.0,"The Daily Biotech Pulse: Illumina's Strong Q3, Celgene's Positive Cancer Drug Trial, Proteostasis Offering",2018-10-24 07:48:00-04:00,EW,positive
448554.0,"Edwards Lifesciences Sees Q4 Adj. EPS $1.05-$1.20 vs $1.21 Est., Adj. Sales $950M-$1B vs $995.4M Est.; Sees FY18 Adj. EPS $4.60-$4.75 vs $4.68 Est., Sales $3.5B-$3.9B vs $3.83B Est.",2018-10-23 16:16:00-04:00,EW,neutral
448555.0,"Edwards Lifesciences Corporation Q3 EPS $1.06 Beats $1.02 Estimate, Sales $907M Miss $928.24M Estimate",2018-10-23 16:15:00-04:00,EW,negative
448556.0,"The Daily Biotech Pulse: Regulus Soars On Positive Pre-Clinical Data, Biogen Earnings, Proteostasis And Eiger to Offer Shares",2018-10-23 08:35:00-04:00,EW,positive
448557.0,Edwards Lifesciences Q3 Earnings Preview,2018-10-23 08:20:00-04:00,EW,neutral
448558.0,"Edwards Comments On German Court Decision Regarding SAPIEN 3 Ultra Valve Patent Infringement Lawsuit; Co. Says Decision Has No Effect On SAPIEN 3 Or CENTRA Sales, Says Will 'Promptly' Appeal",2018-10-23 07:33:00-04:00,EW,negative
448559.0,"Boston Scientific Prevails In German Edwards Lifesciences litigation; Court Rules Edwards' Next-Generation Valve Infringes On Co.'s Patent, Grants Right To Enjoin Sales In Germany",2018-10-23 06:52:00-04:00,EW,neutral
448560.0,"Earnings Scheduled For October 23, 2018",2018-10-23 04:22:00-04:00,EW,neutral
448561.0,"Barclays Initiates Coverage On Edwards Lifesciences with Underweight Rating, Announces $143 Price Target",2018-10-16 07:11:00-04:00,EW,neutral
448562.0,"Morgan Stanley Maintains Overweight on Edwards Lifesciences, Raises Price Target to $157",2018-10-11 09:15:00-04:00,EW,negative
448563.0,"Jim Cramer Gives His Opinion On Mastercard, Dell Technologies And More",2018-10-09 06:41:00-04:00,EW,neutral
448564.0,"Edwards Lifesciences Reports Commencement Of US Pivotal Trial Evaluating Its Self-Expanding CENTERA Transcatheter Valve For Sever, Symptomatic Aortic Stenosis Patients At Intermediate Risk Of Open-Heart Surgery",2018-10-08 16:16:00-04:00,EW,negative
448565.0,Guggenheim Downgrades Edwards Lifesciences to Neutral,2018-10-02 08:48:00-04:00,EW,neutral
448566.0,24 Stocks Moving In Tuesday's Pre-Market Session,2018-10-02 08:05:00-04:00,EW,neutral
448567.0,"The Daily Biotech Pulse: FDA Nods For Adamis, Eli Lilly, Pfizer; Spero, Obseva Report Positive Trial Results",2018-09-28 08:10:00-04:00,EW,positive
448568.0,"Stocks Which Set New 52-Week High Yesterday, September 26th",2018-09-27 09:12:00-04:00,EW,neutral
448569.0,"The Daily Biotech Pulse: Hologic Goes Shopping, Johnson & Johnson Snaps Ties With Geron",2018-09-27 08:20:00-04:00,EW,neutral
448570.0,"Stocks That Made New 52-Week Highs So Far Today Include: Becton Dickinson, PerkinElmer, TJX Companies, Medtronic, Danaher, Mastercard, Visa, Illumina, Motorola Solutions, Salesforce, Ross Stores, Edward Lifesciences, and Boston Scientific",2018-09-26 12:58:00-04:00,EW,positive
448571.0,"Stocks Which Set New 52-Week High Yesterday, September 25th",2018-09-26 11:53:00-04:00,EW,neutral
448572.0,"Benzinga Pro Morning Price Check For Regional ETFs: China ETF (FXI) Up 1.1%, Brazil (EWZ) Up 0.9%, Mexico (EWW) Up 0.6%, Japan (EWJ) Up 0.6%, Canada (EWC) Up 0.2%, US (SPY) Up 0.1%, India (INDA) Down 0.1%, Australia (EWA) Down 0.3%",2018-09-26 10:21:00-04:00,EW,neutral
448573.0,"The Daily Biotech Pulse: Verastem's Chinese Duvelisib Licensing Deal, Aldeyra's Positive Dry Eye Disease Drug Trial",2018-09-26 08:25:00-04:00,EW,positive
448574.0,"Stocks That Made New 52-Week Highs So Far Today Include: Textron, Fiserv, Intuitive Surgical, Mosaic, Paychex, Juniper Networks, F5 Networks, Gartner, Cooper Companies, Edwards Lifesciences, Boston Scientific, Illumina, Yum Brands, and Align Technology",2018-09-25 13:02:00-04:00,EW,neutral
448575.0,"Stocks Which Set New 52-Week High Yesterday, September 24th",2018-09-25 09:06:00-04:00,EW,neutral
448576.0,"The Daily Biotech Pulse: Syndax Lung Cancer Trial Disappoints, Gemphire To Trim Workforce, Opiant's Offering",2018-09-25 08:30:00-04:00,EW,negative
448577.0,Edwards Lifesciences Corp shares are up 7.4% after Abbott Laboratories demonstrated its MitraClip heart failure treatment was superior to medical therapy; NOTE: Edwards is developing a heart failure treatment with its GeoForm heart valve.,2018-09-24 13:54:00-04:00,EW,negative
448578.0,"Stocks That Made New 52-Week Highs So Far Today Include: Amgen, Ross Stores, Marathon Petroleum, Marathon Oil, Medtronic, Humana, Pfizer, Boston Scientific, Edward Lifesciences, and Abbott Labs",2018-09-24 13:13:00-04:00,EW,neutral
448579.0,"Edwards Lifesciences Shares Up 6+% Mon. Morning, Likely Related To News Abbott Showed Treatment With Its MitraClip Is Superior To Medical Therapy; BZ NOTE: Edwards Is Developing A Heart Failure Treatment With Its GeoForm Heart Valve",2018-09-24 10:03:00-04:00,EW,positive
448580.0,"Benzinga Pro Mid-Day Price Check For Regional ETFs: Brazil (EWZ) Up 1.4%, Russia (RSX) Up 0.1%, US (SPY) Down 0.2%, India (INDA) Down 0.2%, Canada (EWC) Down 0.3%, Mexico (EWW) Down 0.3%, Europe (VGK) Down 0.6%, Australia (EWA) Down 0.8%",2018-09-05 12:39:00-04:00,EW,neutral
448581.0,"Benzinga Pro Mid-Day  Price Check For Regional ETFs: China ETF (FXI) Up 2.5%, Mexico (EWW) Up 1.9%, Japan (EWJ) Up 0.9%, Russia (RSX) Up 0.8%, Europe (VGK) Up 0.8%, Brazil (EWZ) Up 0.8%, India (INDA) Up 0.4%, US (SPY) Up 0.4%",2018-08-07 12:44:00-04:00,EW,neutral
448582.0,"Citigroup Maintains Sell on Edwards Lifesciences, Raises Price Target to $118",2018-07-31 07:38:00-04:00,EW,neutral
448583.0,62 Biggest Movers From Friday,2018-07-30 04:16:00-04:00,EW,neutral
448584.0,55 Stocks Moving In Friday's Mid-Day Session,2018-07-27 12:37:00-04:00,EW,neutral
448585.0,"Morgan Stanley Maintains Overweight on Edwards Lifesciences, Raises Price Target to $150",2018-07-27 11:44:00-04:00,EW,negative
448586.0,"Wells Fargo Maintains Outperform on Edwards Lifesciences, Raises Price Target to $170",2018-07-27 11:01:00-04:00,EW,positive
448587.0,"Stocks Which Set New 52-Week High Yesterday, July 26th:",2018-07-27 10:42:00-04:00,EW,neutral
448588.0,"Benzinga's Daily Biotech Pulse: Achaogen To Trim Workforce By 28%, Amgen's Beat-And-Raise Quarter",2018-07-27 08:44:00-04:00,EW,neutral
448589.0,36 Stocks Moving In Friday's Pre-Market Session,2018-07-27 08:08:00-04:00,EW,neutral
448590.0,"JP Morgan Maintains Neutral on Edwards Lifesciences, Raises Price Target to $150",2018-07-27 08:02:00-04:00,EW,positive
448591.0,Edwards Lifesciences Raises FY18 Adj. EPS From $4.50-$4.70 To $4.60-$4.75 vs $4.63 Estimate,2018-07-26 16:17:00-04:00,EW,neutral
448592.0,"Edwards Lifesciences Q2 EPS $1.32 Beats $1.14 Estimate, Sales $943.7M Miss $969.26M Estimate",2018-07-26 16:16:00-04:00,EW,negative
448593.0,"Stocks That Made New 52-Week Highs Earlier Today Include: Alphabet, Adobe, VeriSign, Abbott Labs, Becton, United Continental, IHS Markit, TransDigm, Kansas City Southern, Ingersoll-Rand, VF, Motorola Solutions, AES, Edward Lifesciences, Visa, AMD, & Apple",2018-07-26 11:28:00-04:00,EW,positive
448594.0,"Stocks Which Set New 52-Week High Yesterday, July 25th",2018-07-26 11:00:00-04:00,EW,neutral
448595.0,"Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold",2018-07-26 08:40:00-04:00,EW,negative
448596.0,"Earnings Scheduled For July 26, 2018",2018-07-26 04:20:00-04:00,EW,neutral
448597.0,"Edwards Lifesciences Comments On Centers For Medicare, Medicaid Services Advisory Panel Related To Evidence Pertaining To Procedural Volume Requirements For Transcatheter Aortic Valve Replacement Programs",2018-07-25 18:22:00-04:00,EW,neutral
448598.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs",2018-07-22 17:03:00-04:00,EW,neutral
448599.0,Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR,2018-06-28 08:03:00-04:00,EW,neutral
448600.0,"Bernstein Initiates Coverage On Edwards Lifesciences with Market Perform Rating, Announces $165 Price Target",2018-06-27 07:59:00-04:00,EW,neutral
448601.0,"Stocks That Made New 52-Week Highs Today Include: Ross Stores, F5 Networks, Google, HCA Healthcare, Murphy Oil, Akamai, TJX Companies, Archer-Daniels, ONEOK, Visa, Autodesk, Costco, PayPal, Edward Lifesciences, Facebook and Discovery, Inc",2018-06-20 14:05:00-04:00,EW,neutral
448602.0,"Benzinga's Daily Biotech Pulse: Biohaven Sells Right To Drug, Obseva To Sell Shares",2018-06-19 08:08:00-04:00,EW,positive
448603.0,Connecticut Water Service Offers Update On Go-Shop Period: 'No Proposals or Indications of Interest Received Following Extensive Outreach to More than 50 Potential Bidders',2018-06-18 09:14:00-04:00,EW,positive
448604.0,"Stocks That Made New 52-Week Highs Today Include: Electronic Arts, Intuit, NetApp, Netflix, Republic Services, VeriSign, Union Pacific, Zoetis, Twenty-First Century Fox, Edward Lifesciences, Ansys, and Advance Auto Parts",2018-06-15 13:58:00-04:00,EW,neutral
448605.0,"Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi",2018-06-14 08:11:00-04:00,EW,negative
448606.0,Eversource Reiterates Its Proposal to Acquire Connecticut Water Service For $63.50 Per Share,2018-06-13 16:37:00-04:00,EW,positive
448607.0,"Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111",2018-06-13 07:48:00-04:00,EW,negative
448608.0,"Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate",2018-06-12 08:47:00-04:00,EW,positive
448609.0,"Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index",2018-06-05 08:05:00-04:00,EW,positive
448610.0,"Stocks That Made New 52-Week Highs Today: Salesforce, Microchip, Fiserv, Edwards Lifesciences, Nike, Stryker, Align Tech, NVIDIA, Visa, IDEXX Labs, Ralph Lauren, Extra Space Storage, Kohl's, Macy's, Marathon Petroleum, Baxter, Expeditors Int'l & TransDigm",2018-06-04 16:47:00-04:00,EW,neutral
448611.0,"Benzinga's Top Upgrades, Downgrades For May 31, 2018",2018-05-31 09:23:00-04:00,EW,positive
448612.0,"Raymond James Initiates Coverage On Edwards Lifesciences with Outperform Rating, Announces $152 Price Target",2018-05-31 07:41:00-04:00,EW,neutral
448613.0,Edwards Lifesciences Announces 30-Day Data Confirms Clinical Trial Outcomes For SAPIEN 3 Valve Patients,2018-05-22 09:08:00-04:00,EW,neutral
448614.0,"Benzinga Pro Morning Price Check For Regional ETFs: US (SPY) Flat, Canada (EWC) Flat, Japan (EWJ) Flat, Brazil (EWZ) Down 0.4%, Russia (RSX) Down 0.4%, Europe (VGK) Down 0.5%, India (INDA) Down 0.7%, China ETF (FXI) Down 0.9%",2018-05-04 09:56:00-04:00,EW,neutral
448615.0,"Benzinga Pro Mid-Day Price Check For Regional ETFs: Australia (EWA) Up 1.1%, Europe (VGK) Up 0.5%, Canada (EWC) Up 0.3%, US (SPY) Down 0.2%, China ETF (FXI) Down 0.3%, Japan (EWJ) Down 0.4%, Russia (RSX) Down 0.4%, Mexico (EWW) Down 0.7%",2018-05-02 12:55:00-04:00,EW,neutral
448616.0,Edwards Lifesciences Announces Accelerated $400M Buyback,2018-05-01 08:01:00-04:00,EW,neutral
448617.0,Edwards Lifesciences Granted CE Mark For Its Edwards Cardioband Tricuspid Valve Reconstruction System,2018-04-30 16:58:00-04:00,EW,positive
448618.0,24 Stocks Moving In Wednesday's Pre-Market Session,2018-04-25 08:02:00-04:00,EW,neutral
448619.0,"Benzinga's Biotech Pulse: Takeda Sweetens Shire Offer Again, Menlo's Woes Abound, Earnings Fail to Boost Amgen",2018-04-25 07:46:00-04:00,EW,negative
448620.0,"15 Stocks To Watch For April 25, 2018",2018-04-25 04:04:00-04:00,EW,neutral
448621.0,Edwards Lifesciences Shares Down 7.4% After Hours As So. Issues Downbeat Q2 EPS Guidance,2018-04-24 17:25:00-04:00,EW,positive
448622.0,"Edwards Lifesciences Sees Q2 Adj. EPS $1.05-$1.15 vs $1.17 Est., Sales $950M-$1.0B vs $966M Est.; FY18 Adj. EPS $4.50-$4.70 vs $4.54 Est., Sales $3.5-$3.9B vs $3.85B Est.",2018-04-24 16:19:00-04:00,EW,neutral
448623.0,"Edwards Lifesciences Q1 EPS $1.22 Beats $1.11 Est., Sales $937.5M Beats $932M Est.",2018-04-24 16:18:00-04:00,EW,neutral
448624.0,"Earnings Scheduled For April 24, 2018",2018-04-24 04:14:00-04:00,EW,neutral
448625.0,"The Week Ahead In Biotech: PDUFA Dates, IPOs And More",2018-04-20 14:00:00-04:00,EW,neutral
448626.0,"Boston Scientific Announces It Has Successfully Opposed Edwards Lifesciences In European Patent Dispute, Says European Patent Office Revokes Edward Lifescience's '550 Patent",2018-04-16 16:46:00-04:00,EW,positive
448627.0,Edwards Lifescience Announces It Has Prevailed In U.S. Patent Office Review That Finds Boston Scientific Transcatheter Valve Patent Claims Invalid,2018-03-23 16:51:00-04:00,EW,neutral
448628.0,"Edwards Lifesciences Completes Enrollment In PARTNER 3 Low-Risk CT Sub-Study, Updates Timeline For SAPIEN 3 Ultra System Launch In Europe to Occur Later In 2018 Than Previously Expected",2018-03-21 16:42:00-04:00,EW,neutral
448629.0,"Stocks that Made New 52-Wk Highs Today Include: Fiserv, IDEXX Labs, Western Digital, Fastenal, NextEra Energy, Edward Lifesciences, Electronic Arts, VeriSign, Global Payments; Stocks That Made New 52-Wk Lows Include Kraft-Heinz, Dominion Energy, and AIG",2018-03-16 12:58:00-04:00,EW,positive
448630.0,"Stocks That Made New 52-Wk Lows Today Include: DISH Network, Hasbro, Dominion Energy, The Williams Companies, CVS, Kinder Morgan, Kraft Heinz, and Signet Jewelers; Fiserv and Edward Lifesciences Among Stocks That Made New 52-Wk Highs",2018-03-15 12:47:00-04:00,EW,positive
448631.0,"Stocks That Made New 52-Wk Highs This Morning Include: Edward Lifesciences, Raymond James, NVIDIA, Goldman Sachs, Fastenal, Intercontinental Exchange, Xilinx, CBRE, Bank of America, Oracle, KeyCorp, Intuit, and IHS Markit",2018-03-12 10:42:00-04:00,EW,neutral
448632.0,"Stocks That Made New 52-Wk Highs Today Include Edwards Lifesciences, Micron, and Activision Blizzard",2018-03-08 11:48:00-05:00,EW,neutral
448633.0,Edwards' Self-Expanding Transcatheter Heart Valve Receives CE Mark,2018-02-15 08:00:00-05:00,EW,neutral
448634.0,Form 4 Filing Late Tuesday Showed Edwards Lifesciences CFP Donald Bobo Sold 3.75K Shares At $127.54,2018-02-14 09:24:00-05:00,EW,positive
448635.0,"Edwards Lifesciences Issues Amended 8-K Revising Q4 Earnings Reported On Feb. 1: 'the provision for income taxes for the three and twelve months ended December 31, 2017 is $326.7 million and $451.3, respectively'",2018-02-07 17:10:00-05:00,EW,positive
448636.0,Form 4 Filing Late Tuesday Shows Edwards Lifesciences Sellers Sold 12.02K Shares At Avg. Prices Ranging From $130.58 to $131.66,2018-02-07 12:14:00-05:00,EW,positive
448637.0,Mid-Afternoon Market Update: Crude Oil Down 1.5%; Natural Grocers Shares Drop On Earnings Miss,2018-02-02 14:31:00-05:00,EW,negative
448638.0,"JMP Securities Maintains Market Outperform on Edwards Lifesciences, Raises Price Target to $140.00",2018-02-02 10:55:00-05:00,EW,positive
448639.0,"Barclays Maintains Overweight on Edwards Lifesciences, Raises Price Target to $155.00",2018-02-02 10:15:00-05:00,EW,negative
448640.0,"Morgan Stanley Maintains Overweight on Edwards Lifesciences, Raises Price Target to $138.00",2018-02-02 09:21:00-05:00,EW,negative
448641.0,"Edwards Lifesciences Sees Q1 Sales $900-$950M vs $901M Est., EPS $1.04-$1.14 vs $1.03 Est.",2018-02-01 16:16:00-05:00,EW,neutral
448642.0,Edward Lifesciences Sees FY18 Sales $3.5-$3.9B vs $3.74B Est.,2018-02-01 16:16:00-05:00,EW,neutral
448643.0,"Edwards Lifesciences Q4 EPS $0.94 vs $0.91 Est., Sales $888.5M vs $867.09M Est.",2018-02-01 16:15:00-05:00,EW,neutral
448644.0,"Earnings Scheduled For February 1, 2018",2018-02-01 04:39:00-05:00,EW,neutral
448645.0,Jim Cramer Gives His Opinion On Corning And Medtronic,2018-01-30 07:40:00-05:00,EW,neutral
448646.0,The 10 Most Expensive Stocks In The S&P 500,2018-01-23 13:23:00-05:00,EW,neutral
448647.0,The Top 10 Value Stocks In The S&P 500,2018-01-19 13:12:00-05:00,EW,positive
448648.0,"Jim Cramer Gives His Opinion On Albemarle, Best Buy, Marvell, And More",2018-01-10 07:40:00-05:00,EW,positive
448649.0,"JP Morgan Healthcare Conference Begins Today, Presenters Include: Gilead, Illumina, Seattle Genetics, Biogen, Incyte, Baxter, Regeneron, Walgreens, Alnylam, Edwards Lifesciences, Molina, Alexion, Celgene, Pfizer, Neurocrine Biosciences, and Jazz Pharma",2018-01-08 09:00:00-05:00,EW,positive
448650.0,"Benzinga's Top Upgrades, Downgrades For January 4, 2018",2018-01-04 09:51:00-05:00,EW,positive
448651.0,Barclays Upgrades Edwards Lifesciences to Overweight,2018-01-04 07:33:00-05:00,EW,negative
448652.0,"Evercore ISI Group Initiates Coverage On Edwards Lifesciences with Outperform Rating, Announces $140.00 Price Target",2018-01-03 08:17:00-05:00,EW,neutral
448653.0,JP Morgan Downgrades Edwards Lifesciences to Neutral,2018-01-02 06:18:00-05:00,EW,positive
448654.0,"BMO Reiterates Outperform Rating On Edwards Lifesciences Following Analyst Meeting Due To Conservative FY18 Guidance, Stronger Franchises, Expanding Market Opportunities, Along With Broad And Robust Mitral Portfolio",2017-12-08 10:17:00-05:00,EW,positive
448655.0,"Edwards Lifesciences Sees FY18 Sales $3.5-$3.9B vs $3.71B Est., EPS $4.10-$4.30 vs $4.15",2017-12-07 07:04:00-05:00,EW,neutral
448656.0,Edwards Lifesciences Announces a $1B Buyback,2017-12-07 07:02:00-05:00,EW,neutral
448657.0,Edwards Lifesciences Acquires Harpoon Medical for $100M Upfront and Up to $150M Dependent on Milestones,2017-12-07 06:11:00-05:00,EW,neutral
448658.0,"Edwards Lifesciences To Acquire Harpoon Medical For $100M In Cash, With Another $150 In Milestone Payments",2017-12-06 16:32:00-05:00,EW,neutral
448659.0,UPDATE: Leerink Analyst Covering Edwards Lifesciences Says Expects Co. To Offer FY18 Guidance At This Week's Analyst Meeting Which Is Below Analysts' Expectations,2017-12-04 11:40:00-05:00,EW,neutral
448660.0,"Edwards Lifesciences Shares Tick Lower, Turn Negative, As Traders Circulate Cautious Comments From Leerink Analyst",2017-12-04 11:40:00-05:00,EW,negative
448661.0,"Lightning Round: Jim Cramer Likes Blackstone, UnitedHealth",2017-11-01 08:48:00-04:00,EW,positive
448662.0,"UPDATE: Edwards Lifesciences Says 'Lower costs with transcatheter valve driven by shorter lengths of stay, simpler procedures, fewer hospitalizations and rehab days'",2017-10-31 13:41:00-04:00,EW,negative
448663.0,Edwards Lifesciences Reports SAPIEN 3 Transcatheter Valve Showed Significant Cost Savings Over Surgery In Intermediate Risk Patients,2017-10-31 13:41:00-04:00,EW,negative
448664.0,36 Biggest Movers From Yesterday,2017-10-26 05:10:00-04:00,EW,neutral
448665.0,36 Stocks Moving In Wednesday's Mid-Day Session,2017-10-25 12:45:00-04:00,EW,neutral
448666.0,31 Stocks Moving In Wednesday's Pre-Market Session,2017-10-25 08:08:00-04:00,EW,neutral
448667.0,13 Stocks Moving In Tuesday's After-Hours Session,2017-10-24 17:26:00-04:00,EW,neutral
448668.0,"Edwards Lifesciences Sees Q4 Adj. EPS $0.84-$0.94 vs $0.91 Est., Sales $855M-$895M vs $871.9M Est.",2017-10-24 16:20:00-04:00,EW,neutral
448669.0,"Edwards Lifesciences Reaffirms FY17 Outlook: Sales $3.2B-$3.4B vs $3.39B Est., Adj. EPS $3.65-$3.85 vs $3.78 Est.",2017-10-24 16:20:00-04:00,EW,neutral
448670.0,"Edwards Lifesciences Reports Q3 Adj. EPS $0.88 vs $0.86 Est., Sales $821.5M vs $832M Est.",2017-10-24 16:17:00-04:00,EW,neutral
448671.0,"Earnings Scheduled For October 24, 2017",2017-10-24 04:09:00-04:00,EW,neutral
448672.0,"Jim Cramer Shares His Thoughts On Edwards Lifesciences, AeroVironment And More",2017-10-04 07:49:00-04:00,EW,positive
448673.0,Asia Is Giving These ETFs A Major Boost,2017-08-14 15:46:00-04:00,EW,positive
448674.0,"Edwards Lifesciences Sees Q3 Adj. EPS $0.80-$0.90 vs $0.83 Est., Sales $810M-$850M vs $824.73M Est.; FY17 Adj. EPS Guidance Raised From $3.43-$3.55 To $3.65-$3.85 vs $3.53 Est., Sales $3.2B-$3.4B vs $3.35B Est.",2017-07-26 16:18:00-04:00,EW,neutral
448675.0,"Edward Lifesciences Reports Q2 Adj. EPS $1.08 vs $0.88 Est., Sales $842M vs $840.06M Est.",2017-07-26 16:16:00-04:00,EW,neutral
448676.0,"Earnings Scheduled For July 26, 2017",2017-07-26 04:22:00-04:00,EW,neutral
448677.0,"Earnings Scheduled For July 25, 2017",2017-07-25 05:52:00-04:00,EW,neutral
448678.0,Edwards Lifesciences Reports INSPIRIS RESILIA Valve Received FDA Approval,2017-07-05 09:02:00-04:00,EW,positive
448683.0,Hearing FDA Has Expanded Use of Sapien-3 Artificial Heart Valve for High-Risk Patients; Edwards Shares Spiking Higher,2017-06-05 15:26:00-04:00,EW,positive
448684.0,Edwards Announces Novel Self-Expanding Transcatheter Heart Valve Demonstrates 99% Survival Rate,2017-05-17 04:42:00-04:00,EW,positive
448685.0,"Benzinga's Top Upgrades, Downgrades For May 16, 2017",2017-05-16 09:12:00-04:00,EW,positive
448686.0,"Goldman Sachs Initiates Coverage On Edwards Lifesciences with Buy Rating, Announces $138.00 Price Target",2017-05-16 07:22:00-04:00,EW,neutral
448687.0,"Companies Holding Annual Shareholder Meetings Today Include: Lands' End, Invesco, GrubHub, Ford, CoreCivic, Edwards Lifesciences, BioTelemtry, Noodles & Company, & Norfolk Southern",2017-05-11 09:23:00-04:00,EW,neutral
448688.0,"Deutsche Bank Healthcare Conference Begins Today; Presenters Include Synergy Pharma, Exelixis, AbbVie, Collegium Pharma, Zimmer Biomet, Luminex, CRISPR Therapeutics, & Edwards Lifesciences",2017-05-03 08:22:00-04:00,EW,neutral
448689.0,18 Biggest Mid-Day Gainers For Wednesday,2017-04-26 12:28:00-04:00,EW,neutral
448690.0,3 Reasons To Own Edwards Lifesciences,2017-04-26 12:12:00-04:00,EW,neutral
448691.0,Mid-Morning Market Update: Markets Edge Higher; Twitter Earnings Beat Views,2017-04-26 10:18:00-04:00,EW,neutral
448692.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-04-26 08:22:00-04:00,EW,neutral
448693.0,"Edwards Lifesciences Sees FY17 Sales $3.2-$3.4B vs $3.26B Est., EPS $3.30-$3.45 vs $3.41 Est.; Q2 Sales $810-$850M vs $823M Est., EPS $0.82-$0.92 vs $0.87 Est.",2017-04-25 16:17:00-04:00,EW,neutral
448694.0,"Edwards Lifesciences Reports Q1 EPS $0.94 vs $0.82 Est., Sales $884M vs $777M Est.",2017-04-25 16:16:00-04:00,EW,neutral
448695.0,"Earnings Scheduled For April 25, 2017",2017-04-25 05:03:00-04:00,EW,neutral
448696.0,Edwards Lifesciences Shares Up 0.6% Over Last Min as Traders Circulating Takeover Rumor in Name,2017-04-19 14:11:00-04:00,EW,positive
448697.0,Edwards Lifesciences Gets FDA Clearance for its HemoSphere Monitoring Product,2017-04-19 08:34:00-04:00,EW,neutral
448698.0,BMO On Abbott Labs: 'It's Likely Time For The Stock To Take A Pause',2017-03-14 12:08:00-04:00,EW,neutral
448699.0,Edwards Lifesciences Announces German Court Boston Scientifc's Lotus Valve Infringes One Patent,2017-03-09 06:47:00-05:00,EW,neutral
448700.0,Boston Scientific Announces Favorable Rulings In Edwards Lifesciences Litigation,2017-03-09 05:59:00-05:00,EW,positive
448701.0,Watch These 8 Huge Call Purchases In Tuesday Trade,2017-03-07 04:19:00-05:00,EW,positive
448702.0,Benzinga's Option Alert Recap From March 6,2017-03-06 17:12:00-05:00,EW,positive
448703.0,Option Alert: Edwards Lifesciences Apr 90.0 Calls Sweep: 656 @  ASK  $3.40: 706 traded vs 19 OI:  Earnings 4/25 After Close (est)  $89.41 Ref,2017-03-06 12:16:00-05:00,EW,positive
448704.0,Edwards Lifesciences Says it Will Appeal a UK Court's Decision That One Patent Asserted by Boston Scientific Against SAPIEN 3 is Valid and One is Invalid,2017-03-03 06:54:00-05:00,EW,neutral
448705.0,2017 Promises To Be An Interesting Year For Edwards Lifesciences,2017-02-02 14:46:00-05:00,EW,positive
448706.0,18 Biggest Mid-Day Losers For Thursday,2017-02-02 12:50:00-05:00,EW,negative
448707.0,Edward Lifesciences Down 9% Despite Q4 Beat,2017-02-02 11:42:00-05:00,EW,neutral
448708.0,Mid-Morning Market Update: Markets Open Lower; Facebook Beats Q4 Estimates,2017-02-02 09:57:00-05:00,EW,negative
448709.0,"Benzinga's Top Upgrades, Downgrades For February 2, 2017",2017-02-02 09:28:00-05:00,EW,positive
448710.0,"The Market In 5 Minutes: Facebook Beats, Trump Tweets",2017-02-02 09:27:00-05:00,EW,neutral
448711.0,BTIG Research Downgrades Edwards Lifesciences To Neutral,2017-02-02 07:45:00-05:00,EW,neutral
448712.0,"Edwards Lifesciences Reports Q4 Adj EPS $0.75 vs $$0.72 Est, Sales $768M vs $759.54M Est",2017-02-01 16:16:00-05:00,EW,neutral
448713.0,"Earnings Scheduled For February 1, 2017",2017-02-01 04:09:00-05:00,EW,neutral
448714.0,Edwards Lifesciences Shares Up 1.3%; Guggenheim Earlier Upgraded To Buy,2017-01-03 12:23:00-05:00,EW,positive
448715.0,Edwards Lifesciences Paints A Picture Of A Compelling Future,2016-12-09 13:41:00-05:00,EW,positive
448716.0,The Technical Take On Edwards Lifesciences,2016-12-08 12:40:00-05:00,EW,neutral
448717.0,EW Lifesciences Holding Investor Day Today,2016-12-08 08:31:00-05:00,EW,neutral
448718.0,Edwards Lifesciences Sees FY2017 EPS $3.30-3.45 vs $2.88 Est; Sees Sales $3.0B-3.40B vs $2.98B Est,2016-12-08 07:02:00-05:00,EW,neutral
448719.0,7 Biggest Price Target Changes For Wednesday,2016-12-07 09:41:00-05:00,EW,neutral
448720.0,"Wells Fargo on Edwards Lifesciences: Expect the Story to Evolve at Co.'s December 8 Investor Day, Sees FY17 Outlook Likely Being Conservative; Maintains Outperform",2016-12-07 08:20:00-05:00,EW,positive
448721.0,"Cowen & Co. Maintains Outperform on Edwards Lifesciences, Lowers Target to $120.00",2016-12-07 06:58:00-05:00,EW,negative
448722.0,Mid-Afternoon Market Update: Fang Holdings Drops Following Q3 Results; Recro Pharma Shares Surge,2016-11-28 14:36:00-05:00,EW,positive
448723.0,Mid-Day Market Update: Crude Oil Up Over 2%; PhaseRx Shares Spike Higher,2016-11-28 12:08:00-05:00,EW,negative
448724.0,Mid-Morning Market Update: Markets Open Lower; Edwards Lifesciences To Buy Valtech Cardio,2016-11-28 09:56:00-05:00,EW,negative
448725.0,A Peek Into The Markets: U.S. Stock Futures Signal Lower Start On Wall Street,2016-11-28 07:39:00-05:00,EW,negative
448726.0,Gran Tierra Energy Submitted Winning Bids Totaling $30.4N for Two Blocks which Ecopetrol S.A. Offered as Part of Ronda Campos Ecopetrol 2016,2016-11-28 06:05:00-05:00,EW,positive
448727.0,"Edwards to Buy Valtech Cardio for $340M Cash and Stock, Announces $1B Buyback",2016-11-28 06:02:00-05:00,EW,neutral
448728.0,Edwards Board Approves New $1B Share Repurchase Program,2016-11-28 06:01:00-05:00,EW,positive
448729.0,"Jim Cramer Gives His Opinion On Opko Health, Edwards Lifesciences And GW Pharma",2016-11-15 06:44:00-05:00,EW,neutral
448730.0,"Medtronic Shares Moving Lower Over Last Few Mins as Hearing Data from German Aortic Valve Registry Show Co., Edwards Valves Have Raised Death Risk in Less Sick Patients",2016-11-14 11:47:00-05:00,EW,negative
448731.0,Northland Securities Upgrades Edwards Lifesciences Corporation Common Stock to Outperform,2016-11-08 09:26:00-05:00,EW,positive
448732.0,Technical Alert: Edwards Lifesciences Corp Continues Lower,2016-10-27 13:10:00-04:00,EW,neutral
448733.0,Mid-Afternoon Market Update: Crude Oil Down Over 1.5%; NCR Shares Spike Higher,2016-10-26 15:55:00-04:00,EW,negative
448734.0,12 Biggest Mid-Day Losers For Wednesday,2016-10-26 12:17:00-04:00,EW,negative
448735.0,Mid-Day Market Update: Dow Rises 50 Points; Logitech Shares Gain On Earnings Beat,2016-10-26 12:00:00-04:00,EW,positive
448736.0,Mid-Morning Market Update: Markets Open Lower; Boeing Beats Q3 Estimates,2016-10-26 10:17:00-04:00,EW,negative
448737.0,18 Stocks Moving In Wednesday's Pre-Market Session,2016-10-26 08:25:00-04:00,EW,neutral
448738.0,"Edwards Lifesciences Sees FY16 Adj. EPS $2.82-$2.92 vs $2.88 Est., Sales $2.7B-$3B vs $2.94B Est.",2016-10-25 16:16:00-04:00,EW,neutral
448739.0,"Edwards Lifesciences Sees Q4 Sales $750M-$790M vs $801M Est., Adj. EPS $0.67-$0.77 vs $0.74 Est.",2016-10-25 16:16:00-04:00,EW,neutral
448740.0,"Edwards Lifesciences Reports Q3 Adj. EPS $0.68, Inline, Sales $739.4M vs $749M Est.",2016-10-25 16:15:00-04:00,EW,neutral
448741.0,Can You Guess This Chart?,2016-10-19 07:42:00-04:00,EW,neutral
448742.0,Edwards Receives CE Mark For Hypotension Probability Indicator,2016-10-03 04:01:00-04:00,EW,neutral
448743.0,Edwards Sapien 3 Heart Valve Gets Expanded Indication in Europe,2016-09-19 08:02:00-04:00,EW,neutral
448744.0,Cramer's 11 Stocks To Buy During Fed-Fear Selloffs,2016-09-13 12:21:00-04:00,EW,neutral
448745.0,Edwards Lifesciences Files for Potential Mixed Shelf; Size Not Disclosed,2016-08-29 06:55:00-04:00,EW,neutral
448746.0,Edwards Shares Moving Higher as FDA Has Approved Two Transcatheter Heart Valves,2016-08-18 14:27:00-04:00,EW,positive
448747.0,"UPDATE: Edwards Lifesciences Shares Breaking Above $114, Up ~$1.50 Over Last Min, Up ~2.5% for Session",2016-08-18 14:26:00-04:00,EW,positive
448748.0,Edwards Life Sciences Spikes to High of $115.34 on Volume,2016-08-18 14:26:00-04:00,EW,neutral
448749.0,18 Biggest Mid-Day Gainers For Wednesday,2016-07-27 12:10:00-04:00,EW,neutral
448750.0,Bank of America Upgrades Edwards Lifesciences to Buy,2016-07-27 09:05:00-04:00,EW,neutral
448751.0,Benzinga's Top Upgrades,2016-07-27 09:00:00-04:00,EW,positive
448752.0,Edwards Lifesciences Upgraded To Buy At Bank Of America,2016-07-27 08:35:00-04:00,EW,neutral
448753.0,18 Stocks Moving In Wednesday's Pre-Market Session,2016-07-27 08:33:00-04:00,EW,neutral
448754.0,"After-Market Gainers: AAPL Up 6.06%, SWKS 2.44%, QRVO 2.80%, PNRA 4.54%, LOGM 19.48%, EW 6.56%, JBT 2.53%, NUVA 2.10%",2016-07-26 17:11:00-04:00,EW,neutral
448755.0,Edwards Lifesciences Up 6.56% After Beating Earnings & Revenue Estimates,2016-07-26 17:02:00-04:00,EW,negative
448756.0,Edwards Lifesciences Up 6.56% After Beating Earnings Estimates,2016-07-26 17:01:00-04:00,EW,negative
448757.0,"Edward Lifesciences Reports Q2 Adj. EPS $0.76vs. Est. $0.70, Rev. $759.3M vs. Est. $724.2M",2016-07-26 16:16:00-04:00,EW,neutral
448758.0,"Earnings Scheduled For July 26, 2016",2016-07-26 05:03:00-04:00,EW,neutral
448759.0,Option Alert: EW Aug16 110 Calls: 2750 @  Above Ask!  $3.05: 5549 traded vs 2247 OI:  Earnings 7/26 After Close  $105.78 Ref,2016-07-12 12:23:00-04:00,EW,positive
448760.0,William Blair More Confident Edwards' Durability Concerns Are Overdone,2016-06-21 11:18:00-04:00,EW,positive
448761.0,Benzinga's Top Initiations,2016-06-09 09:18:00-04:00,EW,positive
448762.0,Guggenheim Securities Initiates Coverage on Edwards Lifesciences at Neutral,2016-06-09 06:19:00-04:00,EW,positive
448763.0,"Lawsuit Against Neovasc Comes Back In Favor Of CardiAQ; Ladenburg Thalmann Downgrades, Removes PT",2016-05-20 10:16:00-04:00,EW,positive
448764.0,Edwards Lifescience Awarded $70M In Damages For Trade Secret Misappropriation,2016-05-19 15:37:00-04:00,EW,negative
448765.0,"BTIG Downgrades Johnson & Johnson, Admits Buy Thesis 'Had Some Hits & Misses'",2016-05-13 06:46:00-04:00,EW,positive
448766.0,Jim Cramer Gives His Opinion On Synergy Pharmaceuticals And ABIOMED,2016-04-29 06:34:00-04:00,EW,neutral
448767.0,"Cowen & Company Maintains Outperform on Edwards Lifesciences, Raises PT to $120.00",2016-04-27 07:37:00-04:00,EW,neutral
448768.0,"Edwards Lifesciences Sees FY16 Rev. $2.7-$3B vs. Est. $2.8B, EPS $2.67-$2.77 vs. Est. $2.68",2016-04-26 16:17:00-04:00,EW,neutral
448769.0,"Edwards Lifesciences Reports Q1 EPS $0.71 vs. Est. $0.66, Rev. $697.3M vs. Est. $664M",2016-04-26 16:16:00-04:00,EW,neutral
448770.0,"Earnings Scheduled For April 26, 2016",2016-04-26 04:26:00-04:00,EW,neutral
448771.0,"JP Morgan Maintains Overweight on Edwards Lifesciences, Raises PT to $120.00",2016-04-11 05:49:00-04:00,EW,neutral
448772.0,"Barclays Maintains Equal-weight on Edwards Lifesciences, Raises PT to $105.00",2016-04-07 04:55:00-04:00,EW,neutral
448773.0,Northland Securities Downgrades Edwards Lifesciences to Market Perform,2016-04-05 08:55:00-04:00,EW,positive
448774.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-04-04 16:52:00-04:00,EW,neutral
448775.0,Mid-Afternoon Market Update: Dow Drops Over 50 Points; Edwards Lifesciences Shares Rise Following Positive Trial,2016-04-04 14:41:00-04:00,EW,positive
448776.0,Mid-Day Market Update: Ruckus Wireless Surges On Acquisition News; Smith & Wesson Shares Slide,2016-04-04 12:18:00-04:00,EW,positive
448777.0,Benzinga's Volume Movers,2016-04-04 10:19:00-04:00,EW,neutral
448778.0,Mid-Morning Market Update: Markets Mostly Flat; Alaska Air To Acquire Virgin America For $57/Share,2016-04-04 10:12:00-04:00,EW,neutral
448779.0,Stocks Hitting 52-Week Highs,2016-04-04 10:02:00-04:00,EW,neutral
448780.0,Benzinga's Top Upgrades,2016-04-04 08:48:00-04:00,EW,positive
448781.0,10 Stocks Moving In Monday's Pre-Market Session,2016-04-04 08:20:00-04:00,EW,neutral
448782.0,"BMO Capital Maintains Outperform on Edwards Lifesciences, Raises PT to $114.00",2016-04-04 07:49:00-04:00,EW,neutral
448783.0,"Leerink Swann Maintains Outperform on Edwards Lifesciences, Raises PT to $115.00",2016-04-04 07:45:00-04:00,EW,neutral
448784.0,Edwards Lifesciences Gains 8% Following Positive Trial,2016-04-04 07:36:00-04:00,EW,positive
448785.0,Edwards Lifesciences +9% Premarket @$98 as Co's SAPIEN XT Valve Met Primary Endpoint i PARTNER II Trial,2016-04-04 07:24:00-04:00,EW,neutral
448786.0,"Jefferies Maintains Buy on Edwards Lifesciences, Raises PT to $105.00",2016-04-04 07:06:00-04:00,EW,neutral
448787.0,"BTIG Research Upgrades Edwards Lifesciences to Buy, Announces $115.00 PT, Sees 'many potential catalysts', Believes There Is No True Pure-Play Comparable For Edwards",2016-04-04 06:39:00-04:00,EW,positive
448788.0,"JP Morgan Reiterates Overweight on Edwards Lifesciences, Raises PT to $110.00, Says A Long Period Of Upward Revision To Co's Estimates 'likely to ensue'",2016-04-04 06:35:00-04:00,EW,neutral
448789.0,Edwards Lifesciences Announces SAPIEN XT Valve Meets Primary Endpoint In PARTNER II Trial,2016-04-02 09:21:00-04:00,EW,neutral
448790.0,"Nomura Starts MedTech Group: STJ, BSX, ZBH, EW, MDT, SYK At Buy, BCR At Neutral",2016-03-17 10:04:00-04:00,EW,neutral
448791.0,"Nomura Initiates Coverage on Edwards Lifesciences at Buy, Announces $101.00 PT",2016-03-17 04:15:00-04:00,EW,neutral
448792.0,Edwards Lifesciences Announces Approval for SAPIEN 3 Valve in Japan,2016-03-16 09:15:00-04:00,EW,positive
448793.0,Option Alert: EW Apr16 90.0 Calls: 500 @  ASK  $3.30: 1014 traded vs 2883 OI:  Earnings 4/28  $87.51 Ref,2016-03-11 12:20:00-05:00,EW,positive
448794.0,College Basketball And Stocks: Everyone Loves A Cinderella Story,2016-03-07 15:17:00-05:00,EW,positive
448795.0,Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures,2016-03-02 09:16:00-05:00,EW,positive
448796.0,"Edwards Lifesciences Faces 'Sell Event,' Citi Warns",2016-02-26 10:12:00-05:00,EW,negative
448797.0,Stocks Hitting 52-Week Highs,2016-02-18 10:01:00-05:00,EW,neutral
448798.0,3 Stocks Moving Big In Tuesday's After-Hours Session,2016-02-02 17:16:00-05:00,EW,neutral
448799.0,Earnings Recap For February 2,2016-02-02 16:45:00-05:00,EW,neutral
448800.0,"Edwards Lifesciences Sees FY16 Rev. $2.6-$2.85B vs. Est. $2.69B, EPS $2.57-$2.67 vs. Est. $2.40; Q1 Rev. $640-$680M vs. Est. $642.76M, EPS $0.64-$0.70 vs. Est. $0.59",2016-02-02 16:18:00-05:00,EW,neutral
448801.0,"Edwards Lifesciences Reports Q4 EPS $0.63 vs. Est. $0.62, Rev. $671.1M vs. Est. $648.7M",2016-02-02 16:16:00-05:00,EW,neutral
448802.0,"Earnings Scheduled For February 2, 2016",2016-02-02 04:01:00-05:00,EW,neutral
448803.0,Edwards Receives FDA Approval For Expanded Indication Study Of SAPIEN 3 Valve,2016-01-15 08:31:00-05:00,EW,positive
448804.0,Benzinga's Top Initiations,2016-01-05 09:54:00-05:00,EW,positive
448805.0,Evercore ISI Group Initiates Coverage on Edwards Lifesciences at Hold,2016-01-05 08:27:00-05:00,EW,neutral
448806.0,"Edwards Lifesciences Sees FY16 Sales Of $2.5-$2.75B vs. Est. $2.69B, EPS $2.3-$2.4 ($4.6-$4.8 Pre-Stock Split) vs. Est. $4.78",2015-12-09 09:16:00-05:00,EW,neutral
448807.0,Edwards Lifesciences Announces Two-for-One Stock Split,2015-11-19 16:30:00-05:00,EW,neutral
448808.0,"Citigroup Initiates Coverage on Edwards Lifesciences at Sell, Announces $134.00 PT",2015-11-12 06:36:00-05:00,EW,neutral
448809.0,"Edwards Lifesciences Reports Q3 EPS $1.07 Vs Est $0.98, Sales #615.5M Vs Est $598.29M; Sees Q3 Adj EPS $1.11-$1.21 Vs Est $1.14 & Revs $620M-$660M Vs Est $630.20M; Raises FY EPS To $4.43-$4.53 Vs Est $4.37",2015-10-26 16:20:00-04:00,EW,neutral
448810.0,"Earnings Scheduled For October 26, 2015 (LH, BRCM, WCN, CR, JAKK, EW, SWFT, PMCS, CAKE, TMK, HIG, KN, AGII, WRB, ROP)",2015-10-26 04:28:00-04:00,EW,neutral
448811.0,Hearing Edwards Lifesciences Added To Wells Fargo Priority List,2015-10-19 07:23:00-04:00,EW,positive
448812.0,Edwards SAPIEN XT Valve Receives FDA Approval For Aortic Valve-In-Valve Procedures,2015-10-15 15:15:00-04:00,EW,positive
448813.0,Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year,2015-10-15 14:26:00-04:00,EW,negative
448814.0,"Goldman Remains Constructive on MedTech, Sees 'New Opportunities' Amid Selloff",2015-08-27 08:40:00-04:00,EW,positive
448815.0,Goldman's New Pair Trade Opportunity,2015-07-31 09:20:00-04:00,EW,positive
448816.0,"Edwards Lifesciences Sees Q3 Sales $580M-$620M vs $587M Est., Adj. EPS $0.92-$1 vs $0.98 Est.; FY15 Sales $2.3B-$2.5B vs $2.41B Est., Adj. EPS $4.30-$4.40 vs $4.28 Est.",2015-07-28 16:14:00-04:00,EW,neutral
448817.0,"Edward Lifesciences Reports Q2 EPS $1.02 vs. Est. $1.05, Rev. $616.8M vs. Est. $604.97M",2015-07-28 16:03:00-04:00,EW,neutral
448818.0,"Earnings Scheduled For July 28, 2015",2015-07-28 04:38:00-04:00,EW,neutral
448819.0,5 NYSE Healthcare Stocks With The Highest ROI,2015-07-15 09:30:00-04:00,EW,neutral
448820.0,Stocks Hitting 52-Week Highs,2015-07-13 10:05:00-04:00,EW,neutral
448821.0,Benzinga's Top Upgrades,2015-07-13 09:08:00-04:00,EW,positive
448822.0,"RBC Capital Upgrades Edwards Lifesciences, Sees $5B Market Opportunity",2015-07-13 09:04:00-04:00,EW,positive
448823.0,Northland Securities Upgrades Edwards Lifesciences to Outperform,2015-07-13 08:43:00-04:00,EW,positive
448824.0,RBC Capital Upgrades Edwards Lifesciences to Outperform,2015-07-13 07:24:00-04:00,EW,neutral
448825.0,"Must Watch Stocks for July 13, 2015",2015-07-13 05:24:00-04:00,EW,neutral
448826.0,Benzinga's Weekend M&A Chatter,2015-07-12 20:44:00-04:00,EW,neutral
448827.0,Edwards Lifesciences Announces Purchase of CardiAQ Valve Technologies for ~$400M,2015-07-10 17:02:00-04:00,EW,neutral
448828.0,Benzinga's Top Upgrades,2015-07-06 09:33:00-04:00,EW,positive
448829.0,Morgan Stanley Upgrades Edwards Lifesciences To Overweight,2015-07-06 09:29:00-04:00,EW,negative
448830.0,"Morgan Stanley Overweight Edwards Lifesciences, Potential Product Markets Are Enormous",2015-07-06 08:41:00-04:00,EW,negative
448831.0,"Intuitive Surgical Downgraded At Morgan Stanley, Stock Worth Only $500",2015-07-06 08:34:00-04:00,EW,positive
448832.0,"Morgan Stanley Upgrades Edwards Lifesciences to Overweight, Raises PT to $168.00",2015-07-06 07:51:00-04:00,EW,negative
448833.0,UPDATE: Edwards Receives FDA Approval for SAPIEN 3 Transcatheter Heart Valve,2015-06-18 04:32:00-04:00,EW,positive
448834.0,Hearing Edwards Life Sciences Receives FDA 'Ok' For Artificial Heart Valve - UNCONFIRMED,2015-06-17 15:28:00-04:00,EW,negative
448835.0,Edwards Lifesciences Shares Spike Higher,2015-06-17 15:27:00-04:00,EW,positive
448836.0,Option Alert: Edwards Lifesciences Aug $150 Call; 1166 Contract Trade at Ask @$2.75; Now $137.70,2015-06-16 15:48:00-04:00,EW,positive
448837.0,Benzinga's Top Upgrades,2015-06-09 09:27:00-04:00,EW,positive
448838.0,BMO Capital Upgrades Edwards Lifesciences To  Outperform,2015-06-09 08:26:00-04:00,EW,neutral
448839.0,BMO Capital Upgrades Edwards Lifesciences to Outperform,2015-06-09 06:48:00-04:00,EW,neutral
448840.0,This Company Can Make Open Heart Surgeries A Thing Of The Past,2015-05-31 15:10:00-04:00,EW,neutral
448841.0,4 Biomedical Stocks Canaccord Loves,2015-05-26 12:46:00-04:00,EW,positive
448842.0,Edwards Pauses Enrollment For Early Stage Mitral Program,2015-05-19 09:21:00-04:00,EW,neutral
448843.0,"First One-Year Report Of Outcomes With Edwards SAPIEN 3 Valve Demonstrate High Survival, Low Stroke Rate",2015-05-19 08:46:00-04:00,EW,negative
448844.0,JPMorgan: Time To Buy Edwards Lifesciences,2015-05-12 08:38:00-04:00,EW,neutral
448845.0,"JP Morgan Upgrades Edwards Lifesciences to Overweight, Raises PT to $155.00",2015-05-12 04:23:00-04:00,EW,neutral
448846.0,"JP Morgan Upgrades Edwards Lifesciences to Overweight, Raises PT to $155.00",2015-05-12 04:22:00-04:00,EW,neutral
448847.0,"Edwards Lifesciences Reports Q1 EPS $1.12 vs $1.04 Est., Sales $590.3M vs $585M Est.; Sees Q2 Adj. EPS $1-$1.10 vs $1.05 Est., FY EPS $4.10-$4.30 vs $4.21 Est.",2015-04-23 16:13:00-04:00,EW,neutral
448848.0,Oppenheimer: 3 Healthcare Stocks And 2 Energy Stocks To Buy Now,2015-03-28 11:39:00-04:00,EW,positive
448849.0,"CRT Reiterates On Edwards Lifesciences, Sees 'Many Future Growth Opportunities'",2015-02-04 14:57:00-05:00,EW,positive
448850.0,"Edwards Lifesciences Reports Q4 Adj EPS $1.06 Vs Est $0.95, Sales $618M Vs Est. $610.64M",2015-02-03 16:03:00-05:00,EW,neutral
448851.0,"Earnings Scheduled For February 3, 2015",2015-02-03 04:59:00-05:00,EW,neutral
448852.0,"UPDATE: Morgan Stanley Raises PT On Edwards Lifesciences Corp., Say Upside Now Tied To Bull Case",2014-12-09 10:16:00-05:00,EW,neutral
448853.0,Credit Suisse Raises 2015 TAVI Estimates for Edwards Lifesciences Corp.,2014-12-09 09:21:00-05:00,EW,positive
448854.0,UPDATE: Bank of America Raises PT on Edwards Lifesciences Corp. Following Analyst Day,2014-12-09 08:33:00-05:00,EW,neutral
448855.0,"Morgan Stanley Maintains Equal-weight on Edwards Lifesciences Corporation, Raises PT to $130.00",2014-12-09 04:21:00-05:00,EW,neutral
448856.0,Edwards Lifesciences Corporation Sees FY2015 EPS $3.90-4.10 vs $3.96 Est; Sees Sales $2.30B-2.50B vs $2.49B Est,2014-12-08 08:01:00-05:00,EW,neutral
448857.0,"Bernstein Initiates Coverage on Edwards Lifesciences Corporation at Outperform, Announces $155.00 PT",2014-12-04 17:26:00-05:00,EW,neutral
448858.0,Meet The 5 Companies Loving Obamacare,2014-11-04 20:04:00-05:00,EW,positive
448859.0,Edwards Lifesciences Shares Up Sharply Following Earnings Beat,2014-10-24 15:45:00-04:00,EW,positive
448860.0,"Morgan Stanley Maintains Equal-weight on Edwards Lifesciences Corporation, Raises PT to $120.00",2014-10-24 06:41:00-04:00,EW,neutral
448861.0,Edwards Lifesciences Corporation Sees Q4 EPS $0.89-0.95 vs $0.95 Est,2014-10-23 17:45:00-04:00,EW,neutral
448862.0,Edwards Lifesciences Corporation Reports Q3 EPS of $0.80 vs $0.72 Est; Revenue of $607.40M vs $543.89M Est,2014-10-23 16:21:00-04:00,EW,neutral
448863.0,"Edwards Lifesciences Reports David Pyott, Allergan Chair, CEO, Has Resigned from Board",2014-10-03 16:02:00-04:00,EW,negative
448864.0,"Generation Investment Management Reports 5.2% Passive Stake In Edwards Lifesciences as of September 8, 2014",2014-09-18 09:21:00-04:00,EW,positive
448865.0,Stocks Hitting 52-Week Highs,2014-09-11 10:06:00-04:00,EW,neutral
448866.0,Stocks Hitting 52-Week Highs,2014-07-30 10:32:00-04:00,EW,neutral
448867.0,Morgan Stanley Sees US Market Acceleration Driving Upside Potential For Edwards Lifesciences,2014-07-30 10:10:00-04:00,EW,neutral
448868.0,Edwards Lifesciences Corporation Raises FY2014 EPS Guidance from $3.10 to $3.24-3.34 vs $3.18 Est,2014-07-29 16:36:00-04:00,EW,neutral
448869.0,Edwards Lifesciences Corporation Sees Q3 EPS $0.66-0.72; Sees Sales $530.0M-570.0M,2014-07-29 16:28:00-04:00,EW,neutral
448870.0,Edwards Lifesciences Corporation Reports Q2 EPS of $0.88 vs $0.77 Est,2014-07-29 16:01:00-04:00,EW,neutral
448871.0,"Earnings Scheduled For July 29, 2014",2014-07-29 05:16:00-04:00,EW,neutral
448872.0,Morgan Stanley Modestly Adjusts Share Assumptions For Edwards Lifesciences,2014-07-28 09:37:00-04:00,EW,positive
448873.0,Edwards Receives FDA Clearance For Advanced Noninvasive Monitoring System,2014-06-30 09:16:00-04:00,EW,positive
448874.0,Benzinga's Top #PreMarket Gainers,2014-06-17 08:10:00-04:00,EW,positive
448875.0,"Edwards Lifesciences Receives FDA Approval for SAPIEN XT Valve, Launches in US",2014-06-16 17:25:00-04:00,EW,positive
448876.0,Benzinga's Top Upgrades,2014-06-11 07:46:00-04:00,EW,positive
448877.0,"JMP Securities Upgrades Edwards Lifesciences Corporation to Market Outperform, Announces $97.00 PT",2014-06-11 06:44:00-04:00,EW,positive
448878.0,Market Wrap For May 21: Fed's Minutes Support Wednesday's Bull Run,2014-05-21 16:37:00-04:00,EW,positive
448879.0,"Medtronic Announces Expensive Settlement, Reports In-line Quarter",2014-05-20 11:01:00-04:00,EW,neutral
448880.0,"UPDATE: Medtronic Posts Drop In Q4 Earnings, Settles Patent Dispute With Edwards Lifesciences",2014-05-20 08:45:00-04:00,EW,negative
448881.0,"Edwards Lifesciences Recently Presented Fortis Valve Results, Say Initial Outcome is Disappointing",2014-05-20 08:12:00-04:00,EW,negative
448882.0,Edwards Lifesciences Announces Good Results for SAPIERN 3 Transcatheter Valve,2014-05-20 08:11:00-04:00,EW,positive
448883.0,"UPDATE: Edwards Lifesciences-Intends to Use Upfront Payment, After Taxes, to Repay Outstanding Bank Debt Under Credit Facility",2014-05-20 07:22:00-04:00,EW,positive
448884.0,UPDATE: Medtronic to Pay Edwards $750M,2014-05-20 07:16:00-04:00,EW,negative
448885.0,UPDATE: Medtronic to Pay Edwards $750M and at Lease $40M Annually Through April 2022,2014-05-20 07:16:00-04:00,EW,negative
448886.0,"Edwards Lifesciences, Medtronic Report Global Settlement for Transcatheter V",2014-05-20 07:16:00-04:00,EW,neutral
448887.0,Morgan Stanley Sees Sapien Becoming Leading Product Line for Edwards Lifesciences,2014-04-25 10:33:00-04:00,EW,neutral
448888.0,"Stifel Nicolaus Maintains Buy on Edwards Lifesciences Corporation, Raises PT to $90.00",2014-04-25 07:31:00-04:00,EW,neutral
448889.0,Edwards Lifesciences Corporation Sees Q2 EPS $0.71-0.81 vs $0.76 Est; Sees Sales $525.0M-565.0M vs $543.16M Est,2014-04-24 16:08:00-04:00,EW,neutral
448890.0,Edwards Lifesciences Corporation Sees FY2014 Sales $2.05B-2.25B vs $2.16B Est,2014-04-24 16:05:00-04:00,EW,neutral
448891.0,Edwards Lifesciences Corporation Reports Q1 EPS of $0.76 vs $0.69 Est; Revenue of $522.40M vs $524.41M Est,2014-04-24 16:04:00-04:00,EW,neutral
448892.0,Medtronic Reprots Federal Appeals Court Agrees to Request to Postpone Injunction,2014-04-21 16:39:00-04:00,EW,neutral
448893.0,"Edwards Is Not Looking for Total Ban of Medtronic's Corevalve, Edwards Believes Corevalve Should Remain Available at US Hospitals - Bloomberg",2014-04-16 15:55:00-04:00,EW,negative
448894.0,Market Wrap For April 15: Who Doesn't Love A Turnaround?,2014-04-15 16:30:00-04:00,EW,negative
448895.0,"JP Morgan Upgrades Edwards Lifesciences Corporation to Neutral, Raises PT to $78.00",2014-04-15 07:55:00-04:00,EW,positive
448896.0,"Market Wrap For April 14: Markets Surge on Positive Retail Data, Citi Earnings",2014-04-14 16:36:00-04:00,EW,positive
448897.0,Mid-Afternoon Market Update: Markets Trade in Mixed Session as Organovo Falls,2014-04-14 15:52:00-04:00,EW,neutral
448898.0,Mid-Day Market Update: WebMD Surges On Strong Outlook; Medtronic Shares Slip,2014-04-14 12:47:00-04:00,EW,positive
448899.0,Benzinga's Volume Movers,2014-04-14 10:35:00-04:00,EW,neutral
448900.0,Mid-Morning Market Update: Markets Open Higher; Citigroup Results Beat Estimates,2014-04-14 10:17:00-04:00,EW,neutral
448901.0,Morning Market Losers ,2014-04-14 09:48:00-04:00,EW,negative
448902.0,Morning Market Movers ,2014-04-14 09:38:00-04:00,EW,neutral
448903.0,"CRT Capital Upgrades Edwards Lifesciences Corporation to Buy, Raises PT to $87.00",2014-04-14 09:13:00-04:00,EW,neutral
448904.0,Benzinga's Top #PreMarket Losers,2014-04-14 08:17:00-04:00,EW,negative
448905.0,Benzinga's Top #PreMarket Gainers,2014-04-14 08:12:00-04:00,EW,positive
448906.0,Edwards Lifesciences Shares Rise 13% Premarket Following Court Ruling Preventing Medtronic from Selling CoreValve System in US ,2014-04-14 07:33:00-04:00,EW,positive
448907.0,Medtronic Sahres Fall 5% Premarket on Federal District Court Ruling Preventing Co from Selling its CoreValve System in US as Result of Edwards Lifesciences Patent Infringement Verdict,2014-04-14 07:27:00-04:00,EW,negative
448908.0,"Bank of America Maintains Neutral on Edwards Lifesciences Corporation, Raises PO to $85.00",2014-04-14 07:04:00-04:00,EW,negative
448909.0,Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy,2014-03-31 16:37:00-04:00,EW,positive
448910.0,UPDATE: Bank of America Reiterates on Edwards Lifesciences on Unique Investment Opportunity,2014-03-24 09:25:00-04:00,EW,positive
448911.0,"Bank of America Maintains Neutral on Edwards Lifesciences Corporation, Raises PO to $75.00",2014-03-24 07:25:00-04:00,EW,negative
448912.0,Top 4 NYSE Stocks In The Medical Appliances & Equipment Industry With The Highest EPS,2014-03-24 04:25:00-04:00,EW,positive
448913.0,Merkel Says Did Not Take Decision to Impose Sanctions on Russia over Ukraine Crisis Lightly,2014-03-17 13:32:00-04:00,EW,negative
448914.0,Wells Fargo Upgrades Edwards Lifesciences Corporation to Outperform,2014-03-10 07:32:00-04:00,EW,positive
448915.0,UPDATE: Medtronic Says EPO Has Invalidated Edwards Patent,2014-03-06 13:09:00-05:00,EW,neutral
448916.0,"German FM Says there will be Consequences for EU-Russia Relations If No Rapid De-Escalation Between Russia, Ukraine",2014-03-03 11:59:00-05:00,EW,negative
448917.0,BTIG Research Initiates Coverage on Edwards Lifesciences Corporation at Neutral,2014-02-20 07:53:00-05:00,EW,neutral
448918.0,Shares of Edwards Lifesciences Up ~1.5% Following News of New ~1.5M Share Position by Rosenstein's JANA Partners,2014-02-14 12:38:00-05:00,EW,positive
448919.0,Market Wrap For February 5: Markets Unsure Of Which Direction To Take,2014-02-05 16:47:00-05:00,EW,negative
448920.0,Edwards Lifesciences Corporation Sees Q1 EPS $0.61-0.71 vs $0.71 Est; Sees Sales $500.0M-550.0M vs $525.50M Est,2014-02-03 16:05:00-05:00,EW,neutral
448921.0,Edwards Lifesciences Corporation Reports Q4 EPS of $0.91 vs $0.82 Est; Revenue of $536.0M vs $533.14M Est,2014-02-03 16:05:00-05:00,EW,neutral
448922.0,"Earnings Scheduled For February 3, 2014",2014-02-03 04:23:00-05:00,EW,neutral
448923.0,Edwards Wins CE Mark for Advance Sapien 3 Valve in Europe,2014-01-27 09:16:00-05:00,EW,positive
448924.0,CAFC Publishes Opinion on CoreValve Case: Medtronic Loses Appeal to Edwards,2014-01-22 13:15:00-05:00,EW,negative
448925.0,Bloomberg Reporting Medtronic to Price CoreValve in Same Range as Edwards Lifesciences Sapein,2014-01-17 15:41:00-05:00,EW,neutral
448926.0,UPDATE: Edwards Seeking Permanent Injunction to Enforce Verdict Against Medtronic,2014-01-15 12:41:00-05:00,EW,positive
448927.0,UPDATE: Federal Jury Finds Medtronic CoreValve Willfully Infringes Edwards' Transcatheter Valve Patent,2014-01-15 12:39:00-05:00,EW,neutral
448928.0,Edwards Lifesciences Shares Jump ~3% Following Medtronic News on CoreValve System,2014-01-15 11:45:00-05:00,EW,positive
448929.0,UPDATE: Medtronic Says Jury Awarded Edwards $392.5M in Total Damages,2014-01-15 11:38:00-05:00,EW,negative
448930.0,"Medtronic to Appeal Federal District Court Verdict, Sees Approval of CoreValve by End of FY14",2014-01-15 11:36:00-05:00,EW,positive
448931.0,Edwards Lifesciences Receives FDA IDE Approval to Start SAPIEN 3 Valve for Intermediate Risk Patients,2014-01-13 09:46:00-05:00,EW,positive
448932.0,UPDATE: Citigroup Lowers PT on Edwards Lifesciences Following Annual Investor Meeting,2013-12-10 10:51:00-05:00,EW,negative
448933.0,Benzinga's Top Downgrades,2013-12-10 08:04:00-05:00,EW,positive
448934.0,Wells Fargo Downgrades Edwards Lifesciences Corporation to Market Perform,2013-12-10 07:28:00-05:00,EW,positive
448935.0,Market Wrap For December 9: Investors Digest Further Clues Hinting at An Upcoming Taper,2013-12-09 16:45:00-05:00,EW,neutral
448936.0,"Edwards Lifesciences Reaffirms FY13 Outlook, Sees FY14 Sales $2.05-2.25B vs $2.2B Est.",2013-12-09 08:05:00-05:00,EW,neutral
448937.0,Edwards Lifesciences Names Scott Ullem CFO,2013-12-05 09:16:00-05:00,EW,neutral
448938.0,"Stifel Nicolaus Maintains Buy on Edwards Lifesciences Corporation, Lowers PT to $75.00",2013-12-03 08:24:00-05:00,EW,negative
448939.0,"FDA Says Edwards Lifesciences Was Issued an Urgent Field Safety Notice on Sept. 16th, Edwards is Recalling Unexpired Embol-X System Cannulae",2013-11-04 14:08:00-05:00,EW,positive
448940.0,"Canaccord Slashes Target on Edwards Lifesciences from $94 to $76, Maintains Buy",2013-10-30 12:08:00-04:00,EW,negative
448941.0,UPDATE: J.P. Morgan Downgrades Edwards Lifesciences Corp. as Street Estimates Are Too High,2013-10-30 11:06:00-04:00,EW,neutral
448942.0,Benzinga's Top Downgrades,2013-10-30 08:10:00-04:00,EW,positive
448943.0,"#PreMarket Primer: Wednesday, October 30: Markets Hope For A Mild Day",2013-10-30 06:29:00-04:00,EW,positive
448944.0,"JP Morgan Downgrades Edwards Lifesciences Corporation to Underweight, Lowers PT to $62.00",2013-10-30 06:19:00-04:00,EW,positive
448945.0,Move Lower in Edwards Lifesciences Related to FDA's Decision Not to Hold Panel Review on Medtronic's CoreValve,2013-10-29 14:23:00-04:00,EW,negative
448946.0,Market Wrap for October 28: Investors Push Apple Shares Lower,2013-10-28 17:12:00-04:00,EW,neutral
448947.0,Mid-Day Market Update: Burger King Surges On Upbeat Earnings; Sohu Shares Dip,2013-10-28 12:31:00-04:00,EW,positive
448948.0,Mid-Morning Market Update: Markets Mixed; Merck Profit Beats Estimates,2013-10-28 10:35:00-04:00,EW,positive
448949.0,Edwards Lifesciences Corporation Sees Q4 EPS $0.81-0.85 vs $0.86 Est; Sees Sales $520.0M-550.0M vs $546.10M Est,2013-10-28 09:07:00-04:00,EW,neutral
448950.0,Edwards Lifesciences Corporation Reports Q3 EPS of $0.68 vs $0.66 Est; Revenue of $496.0M vs $491.18M Est,2013-10-28 09:07:00-04:00,EW,neutral
448951.0,"Earnings Scheduled For October 28, 2013",2013-10-28 05:31:00-04:00,EW,neutral
448952.0,Hearing ITG Positive on Edwards Lifescience,2013-10-21 09:36:00-04:00,EW,positive
448953.0,"UPDATE: Citigroup Upgrades Edwards Lifesciences on Upcoming Catalysts, Attractive Risk/Reward",2013-10-16 10:23:00-04:00,EW,positive
448954.0,Citigroup Upgrades Edwards Lifesciences Corporation to Buy,2013-10-16 07:07:00-04:00,EW,neutral
448955.0,"Stifel Nicolaus Maintains Buy on Edwards Lifesciences Corporation, Raises PT to $82.00",2013-10-03 09:01:00-04:00,EW,neutral
448956.0,FDA Approves Revised Labeling for Edward Lifesciences Sapien Transcatheter Valve,2013-09-23 14:14:00-04:00,EW,positive
448957.0,Brent Steady On Non-Violent Solution In Syria,2013-09-11 07:28:00-04:00,EW,positive
448958.0,Edwards Lifesciences Files Automatic Mixed Securities Shelf,2013-09-06 09:33:00-04:00,EW,positive
448959.0,Edwards Lifesciences Receives IDE for US Clinical Trial of Sapien 3,2013-08-05 09:16:00-04:00,EW,neutral
448960.0,Edwards Lifesciences Corporation Sees Q3 Sales $475.0M-505.0M,2013-07-25 16:19:00-04:00,EW,neutral
448961.0,Edwards Lifesciences Corporation Reports Q2 EPS of $0.82 vs $0.76 Est; Revenue of $517.0M vs $514.59M Est,2013-07-25 16:12:00-04:00,EW,neutral
448962.0,"Northland Securities Upgrades Edwards Lifesciences Corporation to Outperform, Raises PT to $74.00",2013-07-18 08:23:00-04:00,EW,positive
448963.0,German Court Finds Medtronic Infringes Edwards' Patent,2013-07-12 08:47:00-04:00,EW,neutral
448964.0,Benzinga's Top Pre-Market Gainers,2013-07-12 08:14:00-04:00,EW,positive
448965.0,Medtronic Issues Statement on Ruling in Germany Regarding Patent Infringement,2013-07-12 05:51:00-04:00,EW,negative
448966.0,New Data on Edwards PERIMOUNT Valves Demonstrate Long-Term Durability in Patients Aged 60 and Younger ,2013-06-17 09:18:00-04:00,EW,neutral
448967.0,Benzinga's Top Pre-Market Losers,2013-06-14 08:23:00-04:00,EW,negative
448968.0,"Credit Suisse Upgrades Edwards Lifesciences Corporation to Outperform, Raises PT to $77.00",2013-06-10 07:34:00-04:00,EW,positive
448969.0,FDA Issues Warning Letter to Edwards Lifesciences Dated May 24th,2013-06-04 09:19:00-04:00,EW,negative
448970.0,Goldman Sachs Reiterates Buy Rating on Edwards Lifesciences Following Detailed Thesis Review,2013-06-03 08:27:00-04:00,EW,neutral
448971.0,UPDATE: Jefferies Maintains Edwards Lifesciences at Buy on Promising Long-Term Opportuity,2013-05-14 15:45:00-04:00,EW,positive
448972.0,"Market Wrap for Wednesday, April 24: Stocks Little Changed as Investors Focus on Earnings Season",2013-04-24 16:22:00-04:00,EW,neutral
448973.0,Mid-Afternoon Market Update: Oil Continues to Rally as NASDAQ Goes Green,2013-04-24 15:43:00-04:00,EW,neutral
448974.0,"Mid-Day Market Update: Buckeye Tech Surges On Acquisition News, DeVry Dips",2013-04-24 12:25:00-04:00,EW,neutral
448975.0,UPDATE: BMO Capital Markets Lowers PT on Edwards Lifesciences Corp. on 1Q13 Results,2013-04-24 12:24:00-04:00,EW,negative
448976.0,"Mid-Morning Market Update: Markets Open Mixed, Ford Q1 Profit Rises",2013-04-24 10:13:00-04:00,EW,positive
448977.0,"Wunderlich Maintains Hold on Edwards Lifesciences Corporation, Lowers PT to $74.00",2013-04-24 10:06:00-04:00,EW,negative
448978.0,"BMO Capital Maintains Market Perform on Edwards Lifesciences Corporation, Lowers PT to $78.00",2013-04-24 08:53:00-04:00,EW,negative
448979.0,"Stifel Nicolaus Maintains Buy on Edwards Lifesciences Corporation, Lowers PT to $81.00",2013-04-24 08:35:00-04:00,EW,negative
448980.0,"Jefferies Maintains Buy on Edwards Lifesciences Corporation, Lowers PT to $85.00",2013-04-24 08:17:00-04:00,EW,negative
448981.0,"Lazard Capital Markets Downgrades Edwards Lifesciences Corporation to Neutral, Removes $100.00 PT",2013-04-24 07:49:00-04:00,EW,neutral
448982.0,"Citigroup Maintains Neutral on Edwards Lifesciences Corporation, Lowers PT to $75.00",2013-04-24 07:46:00-04:00,EW,negative
448983.0,"RBC Capital Downgrades Edwards Lifesciences Corporation to Sector Perform, Lowers PT to $72.00",2013-04-24 07:43:00-04:00,EW,negative
448984.0,Edwards Lifesciences Corporation Sees FY2013 EPS $3.00-3.10 vs $3.27 Est; Sees Sales $2.0B-2.10B vs $2.13B Est,2013-04-23 16:24:00-04:00,EW,neutral
448985.0,Edwards Lifesciences Corporation Sees Q2 EPS $0.75-79.00 vs $0.81 Est; Sees Sales $500.0M-530.0M vs $536.10M Est,2013-04-23 16:24:00-04:00,EW,neutral
448986.0,Edwards Lifesciences Corporation Reports Q1 EPS of $0.72 vs $0.76 Est; Revenue of $496.70M vs $518.60M Est,2013-04-23 16:03:00-04:00,EW,neutral
448987.0,UPDATE: Goldman Sachs Lowers PT on Edwards Lifesciences Following Detailed Model Review,2013-03-28 12:36:00-04:00,EW,negative
448988.0,"Goldman Sachs Maintains Buy on Edwards Lifesciences Corporation, Lowers PT to $106.00",2013-03-28 08:50:00-04:00,EW,negative
448989.0,UPDATE: JP Morgan Lowers PT on Edwards Lifesciences on Sapien US Launch,2013-03-22 13:15:00-04:00,EW,positive
448990.0,"JP Morgan Maintains Neutral on Edwards Lifesciences Corporation, Lowers PT to $82.00",2013-03-22 07:29:00-04:00,EW,positive
448991.0,"JP Morgan Maintains Neutral on Edwards Lifesciences Corporation, Lowers PT to $82.00",2013-03-22 07:23:00-04:00,EW,positive
448992.0,Bank of England's King Says Sees Case for More Asset Purchases to Aid UK Recovery,2013-03-15 14:15:00-04:00,EW,positive
448993.0,"Jefferies Maintains Buy on Edwards Lifesciences Corporation, Raises PT to $114.00",2013-02-05 08:27:00-05:00,EW,neutral
448994.0,UPDATE: Edwards Q4 Profit Surges 44%,2013-02-05 02:01:00-05:00,EW,positive
448995.0,Edwards Lifesciences Corporation Sees Q1 EPS $0.74-78.00 vs $0.77 Est; Sees Sales $505.0M-530.0M vs $517.90M Est,2013-02-04 16:03:00-05:00,EW,neutral
448996.0,"Edwards Lifesciences Corporation Reports Q4 EPS of $0.77, Inline; Revenue of $510.50M vs $500.10M Est",2013-02-04 16:02:00-05:00,EW,neutral
448997.0,UPDATE: Canaccord Genuity Raises PT to $115 on Edwards Lifesciences Ahead of Q4 Results,2013-02-04 12:24:00-05:00,EW,neutral
448998.0,"Canaccord Genuity Maintains Buy on Edwards Lifesciences Corporation, Raises PT to $115.00",2013-02-04 11:56:00-05:00,EW,neutral
448999.0,"Citigroup Reiterates Neutral Rating, $100 PT on Edwards Lifesciences Corp.",2013-02-04 09:55:00-05:00,EW,neutral
449000.0,"Earnings Scheduled For February 4, 2013",2013-02-04 01:16:00-05:00,EW,neutral
449001.0,Benzinga's Top Initiations,2013-01-04 08:20:00-05:00,EW,positive
449002.0,"Japan, US, South Korea Mull Harsher Sanctions on North Korea -Nikkei",2012-12-07 12:35:00-05:00,EW,negative
449003.0,"UPDATE: JP Morgan Reiterates Neutral Rating, Raises PT on Edwards Lifesciences",2012-12-05 12:27:00-05:00,EW,positive
449004.0,"JP Morgan Maintains Neutral on Edwards Lifesciences Corporation, Raises PT to $88.00",2012-12-05 07:54:00-05:00,EW,positive
449005.0,UPDATE: Edwards Lifesciences Reaffirms FY12 Outlook,2012-12-04 09:03:00-05:00,EW,neutral
449006.0,Edwards Lifesciences Corporation Sees FY2013 EPS $3.21-3.31 vs $3.19 Est; Sees Sales $2.10B-2.20B vs $2.13B Est,2012-12-04 09:02:00-05:00,EW,neutral
449007.0,"UPDATE: J.P. Morgan Reiterates Neutral Rating, Lowers PT on Edwards Lifesciences",2012-12-03 12:06:00-05:00,EW,negative
449008.0,UPDATE: Stifel Nicolaus Initiates Edwards Lifesciences at Buy on Growth Outlook  ,2012-11-20 12:23:00-05:00,EW,positive
449009.0,"Stifel Nicolaus Initiates Coverage on Edwards Lifesciences at Buy, Announces PT of $113",2012-11-20 08:27:00-05:00,EW,neutral
449010.0,Edwards Lifesciences Confirms Appeals Court Ruling of Medtronic's Willful Infringement of Transcatheter Valve Patent,2012-11-13 13:38:00-05:00,EW,negative
449011.0,"Edwards Lifesciences Victory vs Medtronic CoreValve Upheld on Appeal, Edwards Can Seek to Block Sales of Medtronic Valve - Bloomberg",2012-11-13 11:21:00-05:00,EW,negative
449012.0,Deutsche Bank   on Edwards Lifesciences,2012-10-24 14:14:00-04:00,EW,neutral
449013.0,"UPDATE: J.P. Morgan Reiterates Neutral Rating, $87 PT on Edwards Lifesciences Corp.",2012-10-22 13:14:00-04:00,EW,neutral
449014.0,"UPDATE: Jefferies & Company Reiterates Buy Rating, Lowers PT on Edwards Lifesciences Corp.",2012-10-22 11:05:00-04:00,EW,negative
449015.0,"UPDATE: Citigroup Downgrades Edwards Lifesciences Corp. to Neutral, Lowers PT",2012-10-22 09:38:00-04:00,EW,negative
449016.0,"UPDATE: Goldman Sachs Group Reiterates Buy Rating, Raises PT on Edwards Lifesciences",2012-10-22 08:46:00-04:00,EW,neutral
449017.0,Benzinga's Top Downgrades,2012-10-22 07:46:00-04:00,EW,positive
449018.0,Benzinga's Top Downgrades,2012-10-22 07:46:00-04:00,EW,positive
449019.0,"Credit Suisse Maintains Edwards Lifesciences at Neutral, Lowers PT from $110 to $96",2012-10-22 07:18:00-04:00,EW,positive
449020.0,"Jefferies & Company Maintains Edwards Lifesciences at Buy, Lowers PT from $125 to $100",2012-10-22 06:57:00-04:00,EW,negative
449021.0,"Jefferies & Company Maintains Edwards Lifesciences at Buy, Lowers PT from $125 to $100",2012-10-22 06:56:00-04:00,EW,negative
449022.0,"Wunderlich Securities Maintains Edwards Lifesciences at Hold, Lowers PT from $104 to $98",2012-10-22 06:34:00-04:00,EW,positive
449023.0,"Wunderlich Securities Maintains Edwards Lifesciences at Hold, Lowers PT from $104 to $98",2012-10-22 06:32:00-04:00,EW,positive
449024.0,"US Stock Futures Up Ahead of Hasbro, Caterpillar Earnings",2012-10-22 06:00:00-04:00,EW,neutral
449025.0,"Citigroup Downgrades Edwards Lifesciences from Buy to Neutral, Lowers PT from $101 to $95",2012-10-22 05:48:00-04:00,EW,negative
449026.0,"Stocks To Watch For October 22, 2012",2012-10-22 01:45:00-04:00,EW,neutral
449027.0,"Goldman Sachs Maintains Edwards Lifesciences at Buy, Raises PT from $105 to $107",2012-10-21 13:19:00-04:00,EW,neutral
449028.0,UPDATE: Edwards Lifesciences Guides Q4 EPS $0.76-0.80 vs $0.79 Est,2012-10-19 16:02:00-04:00,EW,neutral
449029.0,Edwards Lifesciences Reports Q3 EPS $0.58 vs $0.56 Est; Revenues $447.9M vs $448.17M Est,2012-10-19 16:01:00-04:00,EW,neutral
449030.0,FDA Approves Expanded Indication for Edwards Lifesciences' Transcatheter Valve,2012-10-19 15:15:00-04:00,EW,positive
449031.0,FDA Expands Approved Use of Sapien Artificial Heart Valve,2012-10-19 14:53:00-04:00,EW,positive
449032.0,Edwards Lifesciences Spikes Higher,2012-10-19 14:52:00-04:00,EW,neutral
449033.0,"Benzinga Market Primer, Friday October 19",2012-10-19 06:15:00-04:00,EW,neutral
449034.0,"Citigroup Maintains Edwards Lifesciences at Buy, Lowers PT from $105 to $101",2012-10-16 10:53:00-04:00,EW,negative
449035.0,"Citigroup Maintains Edwards Lifesciences at Buy, Lowers PT from $105 to $101",2012-10-16 10:52:00-04:00,EW,negative
449036.0,Investing Pitfalls to Avoid as Earnings Season Swings into Full Gear,2012-10-15 10:15:00-04:00,EW,negative
449037.0,Edwards Lifesciences Acquires BMEYE,2012-10-10 09:01:00-04:00,EW,neutral
449038.0,Earnings Warnings Pile Up; Market Sentiment Takes Turn for Worse,2012-10-10 08:10:00-04:00,EW,negative
449039.0,Benzinga Mid-Afternoon Market Update ,2012-10-09 15:40:00-04:00,EW,neutral
449040.0,"Barclays Maintains Edwards Lifesciences at Equal-weight, Lowers PT from $90 to $85",2012-10-09 12:30:00-04:00,EW,negative
449041.0,"UBS Maintains Edwards Lifesciences at Neutral, Lowers PT from $110 to $95",2012-10-09 11:11:00-04:00,EW,negative
449042.0,Morning Market Losers,2012-10-09 09:56:00-04:00,EW,negative
449043.0,RBC Capital Downgraded Edwards Lifesciences from Top Pick to Outperform,2012-10-09 09:27:00-04:00,EW,positive
449044.0,Edwards Lifesciences Falls 16% Pre-Market on Monday's Lowered Sales Guidance,2012-10-09 08:59:00-04:00,EW,negative
449045.0,Benzinga's Top Pre-Market Losers,2012-10-09 08:28:00-04:00,EW,negative
449046.0,"Piper Jaffray Maintains Edwards Lifesciences at Overweight, Lowers PT from $118 to $105",2012-10-09 08:20:00-04:00,EW,negative
449047.0,"Canaccord Maintains Edwards Lifesciences at Buy, Lowers PT from $123 to $109",2012-10-09 08:09:00-04:00,EW,negative
449048.0,"Goldman Sachs Maintains Edwards Lifesciences at Buy, Lowers PT from $121 to $107",2012-10-09 06:40:00-04:00,EW,negative
449049.0,US Stock Futures Down; Alcoa Earnings In Focus,2012-10-09 06:12:00-04:00,EW,neutral
449050.0,"Stocks To Watch For October 9, 2012",2012-10-09 02:16:00-04:00,EW,neutral
449051.0,Eswards Lifesciences Falls 15% After-Hours,2012-10-08 16:04:00-04:00,EW,neutral
449052.0,"Edwards Lifesciences Q3 Prelim Sales $448M, Had Seen $465-485M",2012-10-08 16:04:00-04:00,EW,neutral
449053.0,"UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Edwards Lifesciences Corp.",2012-09-28 09:56:00-04:00,EW,neutral
449054.0,"Jefferies & Company Maintains Edwards Lifesciences at Buy, Raises PT from $115 to $125",2012-09-28 05:58:00-04:00,EW,neutral
449055.0,"Bank of America Maintains Edwards Lifesciences at Neutral, Raises PO from $103 to $107",2012-07-25 13:57:00-04:00,EW,negative
449056.0,UPDATE: J.P. Morgan Lowers PT on Edwards Lifesciences from $96 to $93,2012-07-25 09:05:00-04:00,EW,negative
449057.0,"Wunderlich Securities Maintains Edwards Lifesciences at Hold, Raises PT from $75 to $104",2012-07-25 08:49:00-04:00,EW,positive
449058.0,"JP Morgan Maintains Edwards Lifesciences at Neutral, Lowers PT from $96 to $93",2012-07-25 06:13:00-04:00,EW,positive
449059.0,"Jefferies & Company Maintains Edwards Lifesciences at Buy, Raises PT from $100 to $115",2012-07-25 06:03:00-04:00,EW,neutral
449060.0,"Deutsche Bank Maintains Edwards Lifesciences at Hold, Raises PT from $80 to $85",2012-07-25 05:53:00-04:00,EW,neutral
449061.0,"Edwards LifeSciences Guides FY Revenue $1.90-1.97B vs $1.96B Est, Guides FY EPS $2.60-2.68 vs $2.66 Est",2012-07-24 16:04:00-04:00,EW,neutral
449062.0,Edward LifeSciences Guides Q3 EPS $0.57-0.61 vs $0.65 Est,2012-07-24 16:03:00-04:00,EW,neutral
449063.0,Edwards Lifesciences Reports Q2 EPS $0.67 vs $0.65 Est; Revenues $482M vs $489.32M Est,2012-07-24 16:01:00-04:00,EW,neutral
449064.0,UPDATE: Credit Suisse Downgrades Edwards Lifesciences to Neutral Post Recent Price Appreciation  ,2012-07-13 10:55:00-04:00,EW,positive
449065.0,"Credit Suisse Downgrades Edwards Lifesciences from Outperform to Neutral, Raises PT from $99 to $110",2012-07-13 06:09:00-04:00,EW,positive
449066.0,UPDATE: Piper Jaffray Raises PT to $118 on Edwards Lifesciences on Lower Risks Ahead  ,2012-07-06 09:28:00-04:00,EW,negative
449067.0,"Piper Jaffray Reiterates Edwards Lifesciences at Overweight, Raises PT from $90 to $118",2012-07-06 06:23:00-04:00,EW,negative
449068.0,Edwards Intuity Valve System Cleared to Begin U.S. Trial  ,2012-07-02 09:01:00-04:00,EW,positive
449069.0,"UBS Upgrades Edwards Lifesciences from Neutral to Buy, Raises PT from $98 to $107",2012-06-26 10:31:00-04:00,EW,neutral
449070.0,"Medtronic, Snyder's-Lance and Other Stocks Insiders Are Buying",2012-06-26 10:13:00-04:00,EW,neutral
449071.0,Benzinga's Top Downgrades,2012-06-26 07:21:00-04:00,EW,positive
449072.0,"UPDATE: Canaccord Genuity Reiterates Buy Rating, Raises PT for Edwards Lifesciences",2012-06-25 10:08:00-04:00,EW,neutral
449073.0,"Canaccord Maintains Edwards Lifesciences at Buy, Raises PT from $103 to $123",2012-06-25 07:29:00-04:00,EW,neutral
449074.0,"UPDATE: Goldman Sachs Reiterates Buy Rating, Raises PT for Edwards Lifesciences",2012-06-18 10:06:00-04:00,EW,neutral
449075.0,"Goldman Sachs Lowers PT on Edwards Lifesciences from $109 to $102, Maintains Buy",2012-06-18 06:34:00-04:00,EW,negative
449076.0,"Barclays Raises PT on Edwards Lifesciences from $80 to $90, Maintains Equal-weight",2012-06-14 12:47:00-04:00,EW,neutral
449077.0,Edwards Lifesciences up 8% on Positive FDA Panel Vote,2012-06-14 12:40:00-04:00,EW,positive
449078.0,Edwards Lifesciences Trading 8.9% Higher on Heavy Volume; Currently at $98.59,2012-06-14 10:15:00-04:00,EW,neutral
449079.0,Edwards Lifesciences Trading 8.9% Higher on Heavy Volume; Currently at $98.59,2012-06-14 10:14:00-04:00,EW,neutral
449080.0,Edwards Lifesciences Trading 4.7% Higher on Positive FDA Panel Vote Wednesday; Currently at $94.84,2012-06-14 09:37:00-04:00,EW,positive
449081.0,Edwards Lifesciences Trading 2.8% Higher on Heavy Volume; Currently at $93.06,2012-06-14 09:32:00-04:00,EW,neutral
449082.0,UPDATE: Citigroup Raises PT to $105 on Edwards Lifesciences on SAPIEN Panel  ,2012-06-14 08:57:00-04:00,EW,neutral
449083.0,UPDATE: Deutsche Bank Raises PT to $80 on Edwards Lifesciences Ahead of Panel Outcome   ,2012-06-14 08:47:00-04:00,EW,neutral
449084.0,UPDATE: Jefferies Raises PT to $100 on Edwards Lifesciences on Positive Panel  ,2012-06-14 08:30:00-04:00,EW,positive
449085.0,"Goldman Sachs Raises PT on Edwards Lifesciences from $99 to $102, Maintains Buy",2012-06-14 07:48:00-04:00,EW,neutral
449086.0,From Earlier: FDA Panel Recommends Approval of Edwards Transcatheter Valve for High-Risk Patients  ,2012-06-14 07:40:00-04:00,EW,positive
449087.0,"Jefferies Raises PT on Edwards Lifesciences from $92 to $100, Maintains Buy",2012-06-14 07:37:00-04:00,EW,neutral
449088.0,"Citigroup Raises PT On Edwards Lifesciences from $84 to $105, Maintains Buy",2012-06-14 05:59:00-04:00,EW,neutral
449089.0,Edwards Receives IDE for U.S. Clinical Trial of New Heart Valve,2012-06-08 09:07:00-04:00,EW,neutral
449090.0,"Canaccord Maintains Edwards Lifesciences at Buy, Raises PT from $93 to $103",2012-06-07 06:48:00-04:00,EW,neutral
449091.0,Deutsche Bank Adds Edwards Lifesciences to Short-Term Sell List,2012-06-06 09:43:00-04:00,EW,neutral
449092.0,Edwards Lifesciences Trading 2.8% Higher on Heavy Volume; Currently at $86.5,2012-06-05 12:44:00-04:00,EW,neutral
449093.0,Edwards Lifesciences' Chairman and CEO to Exercise Stock Options Under 10b5-1 Stock Trading Plan  ,2012-05-07 09:01:00-04:00,EW,neutral
449094.0,"UPDATE: Goldman Sachs Reiterates Buy Rating, Raises PT for Edwards Lifesciences",2012-05-02 09:59:00-04:00,EW,neutral
449095.0,"Goldman Sachs Maintains Edwards Lifesciences at Buy, Raises PT from $90 to $97",2012-05-02 09:04:00-04:00,EW,neutral
449096.0,"Canaccord Maintains Edwards Lifesciences at Buy, Raises PT from $86 to $93",2012-05-01 13:12:00-04:00,EW,neutral
449097.0,Edwards Lifesciences Reports Q1 EPS $0.53 vs $0.48 Est; Revenues $459.2M vs $449.75M Est,2012-04-24 16:02:00-04:00,EW,neutral
449098.0,"JP Morgan Maintains Edwards Lifesciences at Neutral, Lowers PT from $79 to $74",2012-04-13 08:50:00-04:00,EW,positive
449099.0,Edwards Lifesciences: FDA Panel Scheduled to Review Edwards Sapien Valve for High-Risk Patients on June 13  ,2012-04-09 09:02:00-04:00,EW,neutral
449100.0,JP Morgan on Edwards Lifesciences: Sapien Panel Will Have to Wait Until June,2012-03-27 10:57:00-04:00,EW,positive
449101.0,Hearing JP Morgan Making Negative Comments on Edwards Lifesciences,2012-03-27 10:55:00-04:00,EW,negative
449102.0,Citi: Edwards Lifesciences' Data Meets Expectations,2012-03-27 08:19:00-04:00,EW,neutral
449103.0,"Edwards Sapien Death Rate Identical to Surgery After Two Years; Doesn't Trigger Higher Rates of Stroke, Death; Linked to Regurgitation That Raises Death Risk",2012-03-26 09:01:00-04:00,EW,negative
449104.0,"Canaccord Maintains Edwards Lifesciences at Buy, Lowers PT from $90 to $86",2012-03-08 08:28:00-05:00,EW,negative
449105.0,Edwards Lifesciences Files Official Comment on CMS' Proposed TAVR National Coverage Determination,2012-03-05 12:02:00-05:00,EW,positive
449106.0,Edwards Lifesciences Says Restating Earnings Doe to STK Plan Treatment; EPS and Revenue Not Affected,2012-02-27 16:44:00-05:00,EW,positive
449107.0,EDWARDS INTUITY Valve System Receives CE Mark,2012-02-16 09:01:00-05:00,EW,neutral
449108.0,UPDATE: Credit Suisse Upgrades Edwards Lifesciences to Outperform,2012-02-15 08:26:00-05:00,EW,positive
449109.0,"Credit Suisse Upgrades Edwards Lifesciences from Neutral to Outperform, Lowers PT from $90 to $88",2012-02-15 06:00:00-05:00,EW,positive
449110.0,Three Large-Cap Stocks Insiders Are Selling Like Crazy,2012-02-10 12:17:00-05:00,EW,neutral
449111.0,Edwards Lifesciences Falls 10% After Poor Earnings Report,2012-02-03 13:26:00-05:00,EW,negative
449112.0,Goldman Sachs Maintains Buy on Edwards Lifesciences After 4Q Earnings,2012-02-03 09:43:00-05:00,EW,negative
449113.0,Edwards Lifesciences Guides Q1 Revenue $440-460M vs $464.85M Est,2012-02-02 16:32:00-05:00,EW,neutral
449114.0,Edwards Lifesciences Reports Q4 EPS $0.62 vs $0.59 Est; Sales $430.2M vs $446.94M Est	 		,2012-02-02 16:13:00-05:00,EW,neutral
449115.0,UPDATE: Credit Suisse Downgrades Edwards Lifesciences to Neutral,2012-02-02 09:25:00-05:00,EW,positive
449116.0,Benzinga's Top Downgrades,2012-02-02 07:49:00-05:00,EW,positive
449117.0,Credit Suisse Downgrades Edwards Lifesciences to Neutral,2012-02-02 06:01:00-05:00,EW,positive
449118.0,Edwards Lifesciences Up 6% After Positive Cardiac Catheter Data,2012-01-31 15:23:00-05:00,EW,positive
449119.0,Wunderlich Securities Comments on Edwards Lifesciences,2012-01-31 14:49:00-05:00,EW,positive
449120.0,UPDATE: Canaccord Raises Target to $90 on Edwards Lifesciences,2012-01-31 09:25:00-05:00,EW,neutral
449121.0,"Lockheed Martin, Raytheon Team to Provide SEWIP Electronic Attack Capability for U.S. Navy Anti-ship Missile Defense",2012-01-31 09:07:00-05:00,EW,negative
449122.0,Morgan Stanley: Edwards Lifesciences Experiencing Improved Stroke and Mortality Trends,2012-01-31 08:22:00-05:00,EW,positive
449123.0,Edwards Lifesciences Trading 1.2% Higher on Heavy Volume; Currently at $78.07,2012-01-23 13:24:00-05:00,EW,neutral
449124.0,"Edward LifeSciences Spokesperson: Investors, Analysts Seeing Presentation by STS CAP Data to be Positive for the Company, Regarding Price Spike",2012-01-18 14:56:00-05:00,EW,positive
449125.0,Edwards LifeSciences Spiking Higher; Hearing Positive Trial Data,2012-01-18 14:51:00-05:00,EW,positive
449126.0,Edwards LifeSciences Spiking Higher on Heavy Volume,2012-01-18 14:45:00-05:00,EW,neutral
449127.0,UPDATE: JP Morgan Upgrades Edwards Lifesciences to Neutral,2012-01-03 12:20:00-05:00,EW,positive
449128.0,JP Morgan Upgrades Edwards Lifesciences to Neutral,2012-01-03 06:45:00-05:00,EW,positive
449129.0,Raytheon Books $50 Million in Electronic Warfare Contracts ,2011-12-30 09:00:00-05:00,EW,negative
449130.0,Eight Healthcare Stocks Insiders Are Bullish About,2011-12-27 15:04:00-05:00,EW,neutral
449131.0,RBC Capital Upgrades Edwards Lifesciences to Top Pick,2011-12-20 09:59:00-05:00,EW,positive
449132.0,Deutsche Bank Maintains Hold on Edwards Lifesciences After Analyst Meeting,2011-12-12 13:42:00-05:00,EW,neutral
449133.0,"Wells Fargo Maintains Outperform, $86-88 Range on Edwards Lifesciences ",2011-12-12 11:54:00-05:00,EW,positive
449134.0,"JP Morgan Reiterates Underweight, $70 PT on Edwards Lifesciences ",2011-12-12 10:28:00-05:00,EW,positive
449135.0,Morgan Stanley Maintains Equal-Weight on Edwards Lifesciences ,2011-12-12 09:00:00-05:00,EW,neutral
449136.0,Canaccord Upgrades Edwards Lifesciences to Buy,2011-12-12 08:14:00-05:00,EW,neutral
449137.0,Piper Jaffray Maintains Overweight Rating on Edwards Lifesciences,2011-12-12 07:10:00-05:00,EW,negative
449138.0,Morgan Keegan Maintains Outperform Rating on Edwards Lifesciences,2011-12-12 07:03:00-05:00,EW,neutral
449139.0,Goldman Sachs Maintains CL-Buy on Edwards Lifesciences After 2012 Guidance Release,2011-12-09 10:11:00-05:00,EW,neutral
449140.0,Citigroup Maintains Buy on Edwards Lifesciences After Investor Conference,2011-12-09 09:51:00-05:00,EW,neutral
449141.0,Edwards Lifesciences Forecasts Sees 2012 Total Sales of $1.95-2.05B vs $2.01B,2011-12-09 08:32:00-05:00,EW,neutral
449142.0,Edwards Lifesciences Spokesperson Says She has Not Seen Reports from Barclay's and Wells Fargo on Medical Device Makers,2011-12-02 15:55:00-05:00,EW,positive
449143.0,Hearing Twitter Chatter Hospital and Device Stocks Being Hit by Wells Fargo Note; Medicare Carriers Will Perform Pre-Payment Audits Jan ,2011-12-02 15:33:00-05:00,EW,positive
449144.0,Edwards Lifesciences Spiking Lower on Heavy Volume; May be Attributed to Barclay's Report,2011-12-02 15:13:00-05:00,EW,negative
449145.0,Rodman & Renshaw Maintains Market Perform Rating on Edwards Lifesciences ,2011-11-29 08:20:00-05:00,EW,neutral
449146.0,Edwards Lifesciences Hits 52-Week Low of $61.62,2011-11-23 10:29:00-05:00,EW,negative
449147.0,Mad Money Lightning Round: Cramer Likes Waste Management,2011-11-22 04:33:00-05:00,EW,negative
449148.0,"Medtronic Earnings Preview: Analysts Expect Flat EPS, Rising Revenue",2011-11-17 09:43:00-05:00,EW,neutral
449149.0,Rodman & Renshaw Maintains Market Perform on Edwards Lifesciences  ,2011-11-11 09:06:00-05:00,EW,neutral
449150.0,Jefferies Maintains Buy Rating and $92 PT on Edwards Lifesciences ,2011-11-11 07:56:00-05:00,EW,neutral
449151.0,Goldman Sachs Lowers EPS Estimates on Edwards Lifesciences ,2011-11-11 07:40:00-05:00,EW,negative
449152.0,Piper Jaffray Maintains Overweight Rating and $83 PT on Edwards Lifesciences ,2011-11-11 07:35:00-05:00,EW,negative
449153.0,Goldman Sachs Lowers PT on Edwards Lifesciences to $86,2011-11-11 06:07:00-05:00,EW,negative
449154.0,Deutsche Bank Has Hold on Edwards Lifesciences,2011-11-10 15:56:00-05:00,EW,neutral
449155.0,Hearing Lazard Saying Buy Edwards Lifesciences on Weakness,2011-11-10 15:43:00-05:00,EW,negative
449156.0,Edwards Lifesciences Spiking Lower on Heavy Volume,2011-11-10 14:51:00-05:00,EW,negative
449157.0,Edwards SAPIEN Valve's Patient Benefits Increase at Two Years,2011-11-10 14:27:00-05:00,EW,positive
449158.0,Edwards SAPIEN Valve's Patient Benefits Increase at Two Years  ,2011-11-10 14:25:00-05:00,EW,positive
449159.0,Edwards Receives FDA Approval to Expand U.S. Clinical Trial of Next-Generation Transcatheter Valve,2011-11-07 09:00:00-05:00,EW,positive
449160.0,JP Morgan Maintains Underweight Rating and $70 PT on Edwards Lifesciences ,2011-11-03 07:50:00-04:00,EW,positive
449161.0,Edwards Lifesciences Accepts US Coverage Curbs on Heart Valve; May Cut Sales by $100M -Bloomberg,2011-11-02 13:44:00-04:00,EW,positive
449162.0,Edwards Lifesciences Spiking Lower on Heavy Volume,2011-11-02 13:38:00-04:00,EW,negative
449163.0,Morgan Keegan Maintains Outperform on Edwards Lifesciences,2011-11-01 07:31:00-04:00,EW,neutral
449164.0,Morgan Keegan Overweight on Edwards Lifesciences ,2011-10-31 08:00:00-04:00,EW,negative
449165.0,Jefferies Lowers PT on Edwards Lifesciences to $92 Waiting on Notice from the FDA,2011-10-20 10:31:00-04:00,EW,negative
449166.0,Edwards Lifesciences Sees Net Income Climb,2011-10-19 16:23:00-04:00,EW,neutral
449167.0,Edwards Lifesciences Reports Q3 EPS $0.38 vs $0.39 Est; Revenues $412.7M vs $405.03M Est		,2011-10-19 16:02:00-04:00,EW,neutral
449168.0,Notable Put Options Activity in Edwards Lifesciences,2011-10-19 11:14:00-04:00,EW,neutral
449169.0,Piper Jaffray Maintains Overweight Rating on Edwards Lifesciences,2011-10-19 07:33:00-04:00,EW,negative
449170.0,JP Morgan Maintains Underweight Rating and $69 PT on Edwards Lifesciences ,2011-10-18 09:42:00-04:00,EW,positive
449171.0,"Edwards Lifesciences Earnings Preview: Analysts Expect Rising Revenue, Falling EPS",2011-10-14 17:50:00-04:00,EW,negative
449172.0,"St. Jude Medical Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-14 17:50:00-04:00,EW,neutral
449173.0,Goldman Sachs Maintains Buy Rating and $93 PT on Edwards Lifesciences ,2011-10-07 09:01:00-04:00,EW,neutral
449174.0,UPDATE: Piper Jaffray Lowering Price Target on Edwards Lifesciences,2011-10-05 07:45:00-04:00,EW,negative
449175.0,Piper Jaffray Lowers PT on Edwards Lifesciences to $88,2011-10-05 06:08:00-04:00,EW,negative
449176.0,UPDATE: J.P. Morgan Lowers Price Target on Edwards Lifesciences to $69,2011-10-04 07:14:00-04:00,EW,negative
449177.0,JP Morgan Lowers PT on Edwards Lifesciences to $69,2011-10-04 06:12:00-04:00,EW,positive
449178.0,Edwards Lifesciences Comments on CMS National Coverage Analysis of Transcatheter Heart Valves  ,2011-09-29 13:52:00-04:00,EW,neutral
449179.0,Notable Call Options Activity in Edwards Lifesciences,2011-09-29 12:52:00-04:00,EW,neutral
449180.0,UPDATE: Deutsche Bank Lowers PT on Edwards Lifesciences to $75,2011-09-29 09:12:00-04:00,EW,negative
449181.0,J.P. Morgan Underweight on Edwards Lifesciences,2011-09-29 08:25:00-04:00,EW,neutral
449182.0,Deutsche Bank Lowers PT on Edwards Lifesciences to $75,2011-09-29 07:10:00-04:00,EW,negative
449183.0,Edwards Lifesciences CEO to Appear on CNBC,2011-09-28 09:54:00-04:00,EW,neutral
449184.0,Edwards Lifesciences' Board of Directors Approves New $500M Share Repurchase Program  ,2011-09-13 14:38:00-04:00,EW,positive
449185.0,Mad Money Lightning Round: Cramer Likes BHP Billiton,2011-09-13 03:46:00-04:00,EW,negative
449186.0,Goldman Sachs Has Buy On Edwards Lifesciences ,2011-09-06 08:54:00-04:00,EW,neutral
449187.0,UPDATE: Piper Jaffray Lowers Price Target On Edwards Lifesciences To $90,2011-09-02 07:19:00-04:00,EW,negative
449188.0,Piper Jaffray Lowers PT On Edwards Lifesciences To $90,2011-09-02 05:55:00-04:00,EW,negative
449189.0,"Wunderlich Initiates Edwards Lifesciences At Hold, $75 PT",2011-08-24 06:49:00-04:00,EW,neutral
449190.0,Morgan Keegan Reiterates Outperform on Edwards Lifesciences,2011-08-22 07:37:00-04:00,EW,neutral
449191.0,Edwards Lifesciences Pops Higher in After-Hours After a Jim Cramer Mention on CNBC,2011-08-17 18:20:00-04:00,EW,neutral
449192.0,Rodman & Renshaw Upgrades Edwards Lifesciences from Underperform to Market Perform,2011-08-15 09:55:00-04:00,EW,neutral
449193.0,"Rodman & Renshaw Upgrades Edward Lifesciences To Market Perform, $66 PT",2011-08-15 08:20:00-04:00,EW,neutral
449194.0,Credit Suisse Upgrading Edwards Lifesciences ,2011-08-12 09:13:00-04:00,EW,positive
449195.0,"Credit Suisse Upgrades Edwards Lifesciences To Outperform, Lowers PT To $81",2011-08-12 08:35:00-04:00,EW,positive
449196.0,Credit Suisse Upgrades Edwards Lifesciences to Outperform,2011-08-12 07:17:00-04:00,EW,positive
449197.0,"News Summary for August 9, 2011",2011-08-09 07:47:00-04:00,EW,neutral
449198.0,Goldman Sachs Upgrades Edwards Lifesciences to CL-Buy,2011-08-09 06:42:00-04:00,EW,neutral
449199.0,Benzinga's Top Pre-Market Gainers,2011-07-27 07:45:00-04:00,EW,positive
449200.0,Morgan Keenan Upgrades Edwards Lifesciences from Market Perform to Outperform,2011-07-25 08:42:00-04:00,EW,neutral
449201.0,Rodman & Renshaw Downgrades Edwards Lifesciences from Market Perform to Underperform,2011-07-25 08:38:00-04:00,EW,neutral
449202.0,Morgan Stanley Gives Color on Edwards Lifesciences After SAPIEN FDA Panel,2011-07-25 06:46:00-04:00,EW,neutral
449203.0,J.P. Morgan Maintains Underweight on Edwards Lifesciences,2011-07-22 08:15:00-04:00,EW,neutral
449204.0,Bank of America Merrill Lynch Maintains Neutral on Edwards Lifesciences,2011-07-22 07:28:00-04:00,EW,neutral
449205.0,Citi Comments on Edwards Lifesciences Corp Before Product Launch,2011-07-22 06:59:00-04:00,EW,neutral
449206.0,Edwards Lifesciences Earnings: Positive Earnings Streak,2011-07-21 17:22:00-04:00,EW,positive
449207.0,Edwards Lifesciences Bid Lower on Earnings Results ,2011-07-21 16:43:00-04:00,EW,negative
449208.0,Edwards Lifesciences Reports Q2 EPS of $0.49 vs. $0.50 Est; Revenues $431.2M vs. $424.63M Est,2011-07-21 16:02:00-04:00,EW,neutral
449209.0,J.P. Morgan Reiterates Overweight Rating On Xilinx,2011-07-21 08:32:00-04:00,EW,negative
449210.0,J.P. Morgan Underweight On Edwards Lifesciences,2011-07-21 07:40:00-04:00,EW,neutral
449211.0,Morgan Keegan Reports on EW Sapien Approval,2011-07-21 07:40:00-04:00,EW,positive
449213.0,Options Brief: Edwards Lifesciences,2011-07-19 10:15:00-04:00,EW,neutral
449214.0,Credit Suisse Neutral On Edwards Lifesciences ,2011-07-19 09:26:00-04:00,EW,positive
449215.0,Earnings Preview: Edwards Lifesciences Revenue Expected to Rise,2011-07-18 14:55:00-04:00,EW,neutral
449216.0,"St. Jude Medical Earnings Preview: Analyts Expect Higher Earnings, Revenue from Prior Quarter",2011-07-15 10:15:00-04:00,EW,neutral
449217.0,Edwards Lifesciences' Advanced Critical Care Platform Now Available in the U.S. ,2011-07-13 11:01:00-04:00,EW,positive
449218.0,Deutsche Bank Maintains Hold on Edwards Lifesciences,2011-07-12 09:24:00-04:00,EW,neutral
449219.0,Big Name Health Care Stocks Plunging,2011-06-10 15:48:00-04:00,EW,positive
449220.0,Piper Jaffray Reiterates Overweight on Edwards Lifesciences ,2011-06-09 07:22:00-04:00,EW,negative
449221.0,Options Brief: Edwards Lifesciences Corporation,2011-06-07 10:05:00-04:00,EW,neutral
449222.0,Bank of America Merrill Lynch Maintains Neutral on Edwards Lifesciences,2011-06-06 09:09:00-04:00,EW,neutral
449223.0,Morgan Stanley Comments on Edwards Lifesciences ,2011-05-18 08:12:00-04:00,EW,neutral
449224.0,Wedbush Reports Solid Q1 Results For Edwards Lifesciences,2011-04-21 10:19:00-04:00,EW,positive
449225.0,Gabelli Raising Estimates On Edwards Lifesciences Corp (EW),2011-04-21 09:26:00-04:00,EW,neutral
449226.0,"Wedbush Upgrades Edwards Lifesciences To Neutral, PT To $78",2011-04-21 09:01:00-04:00,EW,neutral
449227.0,Deutsche Bank Rates Edwards At Hold,2011-04-21 08:31:00-04:00,EW,neutral
449228.0,J.P. Morgan Raises PT On EW To $78,2011-04-21 07:51:00-04:00,EW,neutral
449229.0,Deutsche Bank Raises PT On Edwards Lifesciences To $85,2011-04-21 07:05:00-04:00,EW,neutral
449230.0,JP Morgan Raises PT On Edwards Lifesciences To $78,2011-04-21 06:18:00-04:00,EW,positive
449231.0,Edwards Lifesciences Reports EPS $0.51 vs. $0.42 Estimate; Revenues $404.5M vs. $384.15M Estimate (EW),2011-04-20 16:21:00-04:00,EW,neutral
449232.0,Edwards Lifesciences' Chairman and CEO to Exercise Stock Options Under 10b5-1 Stock Trading Plan ,2011-04-19 09:08:00-04:00,EW,neutral
449233.0,"Mad Money Lightning Round: Cramer Advises Investors To Buy Fortune Brands (TEVA, SDRL, HCBK, FO, PUDA, BTU, BIDU, SINA, RVBD, HOC, WFT, EW)",2011-04-07 00:22:00-04:00,EW,negative
449234.0,Wedbush Raises PT On Edwards Lifesciences To $75,2011-04-04 08:30:00-04:00,EW,neutral
449235.0,Jefferies Upgrades Edwards Lifesciences To Buy,2011-04-04 08:15:00-04:00,EW,neutral
449236.0,Piper Jaffray Reports On Edward Lifesciences' Clinical Trials,2011-04-04 07:31:00-04:00,EW,neutral
449237.0,Citi Comments On Edwards Lifesciences' One-Year Results,2011-04-04 07:21:00-04:00,EW,neutral
449238.0,Deutsche Bank Maintains Hold On Edwards Lifesciences,2011-04-04 07:12:00-04:00,EW,neutral
449239.0,Citigroup Raises PT On Edwards Lifesciences To $99,2011-04-04 06:44:00-04:00,EW,neutral
449240.0,Jefferies Ups EW To Buy,2011-04-04 06:33:00-04:00,EW,neutral
449241.0,Jefferies Initiates Edwards Lifesciences Corporation at Hold (EW),2011-03-29 08:37:00-04:00,EW,neutral
449242.0,Morgan Stanley Anticipates Rise In EW Share Price,2011-03-24 08:03:00-04:00,EW,positive
449243.0,"Mad Money Lightning Round OT: Cramer Is Not A Buyer Of EW (NLY, CIM, EW, BKI)",2011-03-23 20:40:00-04:00,EW,negative
449244.0,Edwards Lifesciences Receives European Approval of Larger Transcatheter Valve  ,2011-02-24 09:10:00-05:00,EW,positive
449245.0,"Mad Money Lightning Round OT: Cramer Thinks That It Is Time To Sell EW (CCG, IRDM, EW)",2011-02-03 20:33:00-05:00,EW,negative
449246.0,Rewarding Quarter for Edwards - Analyst Blog,2011-02-03 15:51:00-05:00,EW,positive
449247.0,Rewarding Quarter for Edwards - Analyst Blog,2011-02-03 15:34:00-05:00,EW,positive
449248.0,Medtronic Redesigns Trial - Analyst Blog,2011-01-19 17:01:00-05:00,EW,neutral
449249.0,Medtronic Redesigns Trial - Analyst Blog,2011-01-19 16:21:00-05:00,EW,neutral
449250.0,Stereotaxis' New Distribution Deal - Analyst Blog,2011-01-06 18:30:00-05:00,EW,neutral
449251.0,Stereotaxis' New Distribution Deal - Analyst Blog,2011-01-06 18:07:00-05:00,EW,neutral
449252.0,BSX Completes Sadra Acquisition - Analyst Blog,2011-01-05 09:33:00-05:00,EW,neutral
449253.0,BSX Completes Sadra Acquisition - Analyst Blog,2011-01-05 08:45:00-05:00,EW,neutral
449254.0,JP Morgan Introduces 2011 Estimates On Edwards Lifesciences,2010-12-31 08:13:00-05:00,EW,positive
449255.0,Options Brief: Edwards Lifesciences Corporation (EW),2010-12-30 15:11:00-05:00,EW,neutral
449256.0,St. Jude Intros Trifecta in Canada - Analyst Blog,2010-12-20 15:30:00-05:00,EW,neutral
449257.0,St. Jude Intros Trifecta in Canada - Analyst Blog,2010-12-20 14:55:00-05:00,EW,neutral
449258.0,Takeover Candidates In Medical Tech ,2010-12-20 14:31:00-05:00,EW,neutral
449259.0,"Mad Money Lightning Round: Cramer Advises Investors To Sell Trina Solar (RIMM, EXC, TSL, TIE, ATI, TJX, M, EW)",2010-12-20 04:08:00-05:00,EW,negative
449260.0,'Mad Money Lightning Round': Dump Trina,2010-12-17 19:20:00-05:00,EW,negative
449261.0,Calls Purchased on Edwards Lifesciences (EW),2010-12-15 13:11:00-05:00,EW,neutral
449262.0,Edwards Lifesciences Sees Growth  - Analyst Blog,2010-12-14 18:33:00-05:00,EW,positive
449263.0,Edwards Lifesciences Sees Growth  - Analyst Blog,2010-12-14 17:51:00-05:00,EW,positive
449264.0,Citigroup Lowers Edwards Lifesciences EPS Estimates,2010-12-14 10:00:00-05:00,EW,negative
449265.0,"US Airways: Analysts' New Targets, Estimates",2010-12-14 08:56:00-05:00,EW,neutral
449266.0,Piper Jaffray Reinforces Overweight Rating on Edwards Lifesciences,2010-12-14 08:16:00-05:00,EW,negative
449267.0,JP Morgan Raises PT On Edwards Lifesciences,2010-12-14 08:08:00-05:00,EW,positive
449268.0,Calls Purchased on Edwards Lifesciences (EW),2010-12-13 10:28:00-05:00,EW,neutral
449269.0,Edwards Stays Neutral - Analyst Blog,2010-12-10 18:33:00-05:00,EW,neutral
449270.0,Edwards Stays Neutral - Analyst Blog,2010-12-10 17:46:00-05:00,EW,neutral
449271.0,Options Brief: Edwards Lifesciences Corporation (EW),2010-12-08 13:16:00-05:00,EW,neutral
449272.0,"Rydex Launches Five Equal Weight ETFs (EWRI, EWRS, EWRM, EWEF, EWEM)",2010-12-08 11:02:00-05:00,EW,neutral
449273.0,BSX to Acquire Sadra Medical - Analyst Blog,2010-11-22 10:06:00-05:00,EW,neutral
449274.0,BSX to Acquire Sadra Medical - Analyst Blog,2010-11-22 04:42:00-05:00,EW,neutral
449275.0,Encouraging Data from Edwards - Analyst Blog,2010-11-16 16:03:00-05:00,EW,positive
449276.0,Citigroup Maintains Edwards Lifesciences Buy Rating And $79 PT,2010-11-12 07:44:00-05:00,EW,neutral
449277.0,Underperform Rating Reiterated on Edwards Lifesciences ,2010-10-26 11:32:00-04:00,EW,neutral
449278.0,Goldman Sachs Reiterates Neutral Rating on Edwards Lifesciences (EW),2010-10-26 10:28:00-04:00,EW,neutral
449279.0,Edwards Lifesciences Beats on EPS; Revenues Light (EW),2010-10-25 16:45:00-04:00,EW,neutral
449280.0,"Top 4 Mid-Cap Stocks In The Medical Appliances & Equipment Industry With The Highest Cash (VAR, HOLX, SNN, EW)",2010-10-21 04:57:00-04:00,EW,positive
449281.0,MDT Advances with its Valve Program - Analyst Blog,2010-10-18 14:03:00-04:00,EW,neutral
449282.0,Edwards Lifesciences Upgraded To Market Perform,2010-09-27 10:03:00-04:00,EW,neutral
449283.0,BMO Raises Price Target On Edwards Lifesciences (EW),2010-09-27 09:30:00-04:00,EW,neutral
449284.0,Edwards' Trial Data Encouraging - Analyst Blog,2010-09-25 13:00:00-04:00,EW,positive
449285.0,PT Changes From RBC Capital,2010-09-24 10:35:00-04:00,EW,neutral
449286.0,Edwards Lifesciences (EW) Hits 52 Week High,2010-09-23 14:44:00-04:00,EW,neutral
449287.0,Edwards Lifesciences Is Skyrocketing,2010-09-23 11:51:00-04:00,EW,neutral
449288.0,"Benzinga's Top Upgrades (PT, EW, ENDP, AMTD)",2010-09-23 08:06:00-04:00,EW,positive
449289.0,"PARTNER B Does Not Disappoint, According to Citi",2010-09-23 08:01:00-04:00,EW,positive
449290.0,Edwards Receives Approval to Begin U.S. Clinical Trial (EW),2010-09-23 07:58:00-04:00,EW,positive
449291.0,Piper Jaffray Upgrades Edwards Lifesciences ,2010-09-23 07:50:00-04:00,EW,neutral
449292.0,Deutsche Bank Raising Price Target On Edwards Lifesciences,2010-09-23 07:28:00-04:00,EW,neutral
449293.0,New PT For Edwards Lifesciences,2010-09-23 07:04:00-04:00,EW,neutral
449294.0,"Big Gainers On The Day (EW, JOBS, EBIX)",2010-09-21 15:54:00-04:00,EW,neutral
449295.0,Edwards' Trial Results Expected - Analyst Blog,2010-09-16 18:03:00-04:00,EW,neutral
449296.0,St. Jude Launches Costa Rica Plant - Analyst Blog,2010-09-16 16:33:00-04:00,EW,neutral
449297.0,Deutsche Bank Initiations For 9/10,2010-09-10 08:34:00-04:00,EW,neutral
449298.0,Deutsche Bank Initiations For 9/10,2010-09-10 08:33:00-04:00,EW,neutral
449299.0,Edwards Initiated at Neutral - Analyst Blog,2010-09-09 16:36:00-04:00,EW,neutral
449300.0,AAI Delivers EW Simulator to U.S. Navy   ,2010-09-09 10:00:00-04:00,EW,neutral
449301.0,Protection Purchased on Edwards Lifesciences (EW),2010-09-08 10:57:00-04:00,EW,neutral
449302.0,"Deutsche Bank Out With Potential Additions To S&P 500 (WLT, ASH, BWA, JEF, CXO)",2010-09-01 15:46:00-04:00,EW,neutral
449303.0,Good News for Boston Scientific  - Analyst Blog,2010-08-12 15:07:00-04:00,EW,positive
449304.0,William Blair Reiterates Outperform on DexCom (DXCM),2010-08-04 09:52:00-04:00,EW,neutral
449305.0,Edwards Lifesciences Up 3.5% On Earnings News (EW),2010-07-21 16:49:00-04:00,EW,neutral
449306.0,Edwards Lifesciences Beat on Top and Bottom Line (EW),2010-07-21 16:13:00-04:00,EW,positive
449307.0,Piper Jaffray Reiterates Neutral Rating on Edwards Lifesciences (EW),2010-07-15 09:27:00-04:00,EW,neutral
449308.0,"Benzinga’s Top Downgrades (EW, RNOW, TEX, FCN)",2010-07-07 07:50:00-04:00,EW,positive
449309.0,Piper Jaffray Maintains Neutral Rating On Edward Lifesciences Corp. (EW),2010-05-24 11:55:00-04:00,EW,neutral
449310.0,Gold And Silver: Big Moves Expected,2010-04-26 13:14:00-04:00,EW,neutral
449311.0,"Goldman Sachs' Outlook For Medical Technology (COV, EW)",2010-04-20 13:41:00-04:00,EW,neutral
449312.0,"Benzinga’s Top Downgrades (FFCH, GRT, EW, CASY, FCX)",2010-04-12 10:36:00-04:00,EW,positive
449313.0,Credit Suisse Raises Price Target for Edwards Lifesciences (EW),2010-04-06 13:04:00-04:00,EW,positive
449314.0,"Healthcare Conference Update (JNJ, BSX, ATEC, BAX, ZOLL)",2010-02-22 17:22:00-05:00,EW,neutral
449315.0,"Edwards Life Sciences Corp. Maintains Buy Rating From Goldman Sachs (EW, GS)",2010-02-22 11:00:00-05:00,EW,neutral
449316.0,"Three Stocks With New Share Buyback Programs (PM, EW, WYN)",2010-02-12 07:51:00-05:00,EW,positive
449317.0,Edward Lifesciences Corporation (EW) Fourth Quarter Preview,2010-02-03 14:48:00-05:00,EW,neutral
449318.0,"New Products And Scale Expected To Drive Med Tech This Year  (MDT, EW, COV, SYK, BAX, NSPH)",2010-01-08 12:14:00-05:00,EW,neutral
449319.0,"Company News for January 08, 2010 - Corporate Summary",2010-01-08 09:20:00-05:00,EW,neutral
449320.0,Lifesciences : Blast From The Past;A Medtech Growth Story,2009-12-16 10:07:00-05:00,EW,positive
449321.0,"Benzinga’s Top Upgrades (SYNA, EP, MCRS, ENR, CNTY, EW, CLWR)",2009-12-11 09:19:00-05:00,EW,positive
449322.0,Edward Lifescience Corp. (EW) To Remain Conservative,2009-12-07 03:50:00-05:00,EW,neutral
449323.0,67 Stocks Returning 50%+ the Past Month,2009-08-28 14:56:00-04:00,EW,neutral
